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RESUMO 
 
Introdução: As células Natural Killer (NK) parecem constituir a primeira linha de defesa 
contra as células tumorais. A relevância das células NK é suportada pela associação 
entre uma diminuição da actividade, ou baixa quantidade de células NK circulantes em 
pacientes com progressão tumoral. No carcinoma colorectal (CRC), uma diminuição da 
actividade e do número de células NK parece estar associado a um pior prognóstico. De 
acordo com dois estudos chineses, a acupunctura e a moxabustão (AcuMoxa) poderão 
ter um impacto positivo nas células NK no CRC, as quais podem ser distinguidas em dois 
subtipos: citotóxico (NKdim) e imunoregulador (NKbright). Contudo, o efeito da acupunctura 
na sua expressão permanece por esclarecer. 
Objectivo: Determinar os efeitos da AcuMoxa no sistema imune dos doentes com CRC, 
principalmente o seu efeito nas células NK e seus subtipos. 
Métodos: Doentes com CRC serão recrutados a partir do Departamento de Oncologia do 
Centro Hospitalar S. João e distribuídos em dois grupos: o grupo experimental (n=9) e o 
grupo de controlo (lista de espera; n=9). No grupo experimental, os doentes serão 
submetidos a tratamento de AcuMoxa segundo o Modelo de Heidelberg de Medicina 
Tradicional Chinesa (8 sessões/mês). Serão efectuadas colheitas de sangue periférico 
em quatro tempos distintos: a primeira colheita (t=0) será efectuada na semana anterior 
ao tratamento de quimioterapia e as restantes três colheitas, a cada 8 dias. O tratamento 
de AcuMoxa consistirá dos pontos LI4, TB5, SP9, Lv3, St36, GB39, PC5 e Lu7. 
Parâmetros primários: Hemograma completo; linfócitos T e B, células NK e subtipos 
NKdim/ NKbright quantificados por citometria de fluxo.  
Parâmetros secundários: Avaliação dos níveis de ansiedade e depressão bem como 
a qualidade de vida (QOL).  
Análise estatística: Os resultados serão analisados dentro de cada grupo e entre os 
grupos (antes e depois da intervenção).  
Discussão: Dois estudos abordaram a modulação da actividade dos subtipos de células 
NK em doentes oncológicos. Baseado nestes dados sobre acupunctura e células NK, 
pretendemos confirmar uma melhoria do status imune, mais especificamente nas células 
NK. Adicionalmente, esperamos revelar qual o subtipo NK mais prevalente durante cada 
fase da QT / intervenção (T0, T1,T2 e T3) incluindo a magnitude do rácio NKdim/ NKbright. 
Conclusão: O tratamento de AcuMoxa segundo o Modelo de Heidelberg poderá 
promover a actividade das células NK, especificamente a sua citotoxicidade, de acordo 
com a literatura. No futuro, este tratamento complementar poderá ter um impacto positivo 
no prognóstico e na QOL dos doentes com CRC. 
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ABSTRACT 
 
Introduction 
NK cells appear to represent a first line of defence against tumour cells. This relevance of 
NK cells is supported by an association between decreased activity or low numbers of 
circulating NK cells in patients with progression of cancers. In colorectal cancer (CRC), 
decreased activity and low number of NK cells appears to be associated with a worse 
prognosis. According to two Chinese studies, acupuncture and moxibustion may have a 
positive impact on NK cell, which can be distinguished in two subsets: cytotoxic (NKdim) 
and immunoregulatory cells (NKbright). However, the effect of acupuncture on its 
expression remains unclear. 
Objectives: To assess the effect of acupuncture and moxibustion on the immune function 
of colorectal cancer patients.  
Methods: CRC patients recruited from the Oncology department of Centro Hospitalar S. 
João, were randomized in two groups, intervention (n=9) and control/waiting list (n=9). In 
the intervention group, patients were submitted to acu-moxibustion treatment protocol 
based on the Heidelberg Model of TCM (8 sessions/ month). Blood samples will be 
collected at baseline (T0) on the week prior to chemotherapy and the following samples 
are collected every once a week until next chemotherapy (CT) regimen. The 
acupuncture/moxa treatment will consist of the points LI4, TB5, SP9, Lv3, St36, GB39, 
PC5 and Lu7. 
Primary Outcome: Complete Blood counts, T and B lymphocytes, NK cells, NKdim/ NKbright 
counts by flow cytometry.  
Secondary Outcomes: Assessment of anxiety and depression levels as well as quality 
of life. 
Statistical analyses:  Results will be analysed within each group (before and after 
intervention) and co- relational comparison between groups 
Discussion: two studies have addressed modulation of NK cells subset activity in cancer 
patients. Based on these data on acupuncture and NK activity, we would like to confirm a 
improvement in immune status and more specifically in NK cells. In addition, we hope to 
unveil which NK subset is more prevalent during each phase of the CT / intervention (T0, 
T1, T2 and T3) regimen, including magnitude of NK dim/ bright ratio.  
Conclusion: Acupuncture/moxa treatment according to the Heidelberg Model may 
promote NK cells activity, especially cytotoxic according to literature. In the future, this 
complementary treatment might have a positive impact in the prognosis and QOL of CRC 
patients in the future. 
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1. Immunoediting Theory 
 
Cancer is widely considered to be a cell-autonomous genetic disease that results 
from alterations in oncogenes, tumour-suppressor genes and genome-stability genes. 
However, the tumour-cell microenvironment, the stroma and immunity also have a major 
role in cancer. Indeed, for the development of a neoplasia, cancer cells have to overcome 
intrinsic (cell autonomous) and extrinsic (immune mediated) barriers to oncogenesis.  
 
Initial studies on cancer immunobiology, proposed the hypothesis of 
“immunosurveillance”: the immune system is able to recognize and destroy proliferating 
cancer cells, which express unique antigens at surface that are by-products of the process 
of malignant transformation and the immune system’s capacity for surveillance can be 
modified through both medical and lifestyle interventions. Initially, was proposed that an 
impaired immune system would fail to react even to a highly immunogenic tumour and this 
impairment was due to genetic factors, radiotherapy or immunosuppressive drugs. 
Nowadays, it is know that, except for hormone therapy, all conventional treatments for 
cancer can suppress immune response.1 
Later studies recognized the existence of a highly complex interrelationship 
between cancer and the immune system and suggested the replacement of the term 
“immunosurveillance” by a more comprehensive term, “immunoediting” (figure 1). The 
cancer immunoediting process engenders three phases: a) elimination phase, in which 
cancer cells are recognized by the immune system and may be eradicated; b) equilibrium 
phase appears if elimination is unsuccessful, and immune system and cancer cells 
achieve an equilibrium in which cancer is contained but not eliminated and c) the escape 
phase appears as result of constant pressure from the immune system, cancer cells can 
undergo genetic alterations becoming resistant to immune attack and, thus, are free to 
grow even in the presence of an intact immune system.2 
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Figure 1: Cancer immunoedting theory. Diverse immune cells involved in the different 
phases. Extracted from Swann et al, 2007 
3 
 
Elimination phase represents the classical concept of cancer immunosurveillance. 
As reviewed by Dunn4, cancer immunosurveillance has two critical effectors functions: 
IFNγ production and cytotoxicity. Interferon (IFN) γ facilitates development of powerful 
anti-tumour effector functions mediated by both adaptive and innate immunity: generation 
of tumour-specific CD4+ Th1 T cells and cytolytic T cells (CTL) and activation of cytocidal 
activity in macrophages. Moreover, IFNγ has the capacity to upregulate tumour 
immunogenicity, explaining the effects on tumour detection and elimination in 
immunocompetent hosts. Perforin was identified as a critical cytolytic molecule in the 
primary host anti-tumour response. 
The molecular definition of tumour antigens provides a firm basis for how the 
adaptive immune system discriminates between normal and neoplasic cells. The tumour 
antigens are recognized by CD8+ β T cells in the context of MHC class II and class I 
proteins, respectively. 
Another important component used by both adaptive and innate cells to distinguish 
cancer cells from normal cells a receptor expressed on the surface of NK cells, the 
NKG2D-activating receptor. NKG2D binds to the MHC class I chain-related proteins A 
 Irene Pais   3 
an B, to the UL16 binding proteins and to the lymphocyte effector cell toxicity-activating 
ligand (LETAL). 
According to the immunoediting hypothesis, tumour’s immunogenic phenotype is 
continuously shaped by the immunological factors in its environment and, thus, the 
dynamic interaction between immunity and cancer in the equilibrium phase produces new 
populations of tumour cells, unstable and rapidly mutating cells. In the equilibrium phase, 
the tumour has three possible outcomes: eventual elimination by the immune system; 
permanent maintenance in the equilibrium phase by cellular and molecular controls of 
immunity, or escape from immune pressure and transit to the final escape phase of the 
immunoediting process. 
In the escape phase, tumour growth proceeds unrestrained by immune pressure. 
To become clinically detectable in an immunocompetent host, cancer cells must 
circumvent both innate and adaptive immunologic defences. It has been proposed several 
mechanisms through which tumour escape from immune control. Tumour escape can be 
a) a direct consequence of alterations occurring in edited tumour targets themselves, like 
for instance tumour cells develop lesions in antigen processing and presentation 
pathways that facilitate evasion from adaptive immune recognition; b) due to the inhibition 
of the protective functions of the immune system; and c) due to suppression of pro-
inflammatory danger signals.4 
 
Tumour microenvironment 
Robert Strausberg2 highlights the importance of studying the genetics and 
phenotypes of the tumour surrounding microenvironment, as well as the cancer cells. In 
fact, there is compelling evidence that the innate and adaptive immune cells of the tumour 
microenvironment engage an extensive and dynamic crosstalk with cancer cells, through 
direct contact or by chemokine and cytokine production5, leading to conclude that tumour 
related-inflammation and anti-tumour immunity co-exist at different points along tumour 
progression and that the environmental and micro environmental conditions dictate the 
balance between the two. 
In fact, some studies6,7,8 show that several components of the tumour 
microenvironment plays an important role in promoting tumour progression. Tumour 
stroma, containing fibroblasts, inflammatory cells and endothelial cells, plays an important 
role in promoting tumour progression; where myofibroblast-driven desmoplasic stromal 
reaction is considered to be a poor prognostic indicator in primary CRC. Several cytokines 
(TGF-beta, PDGF, IL4 and IGF II), that induce myofibroblastic differentiation, seem to 
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have pro-oncogenic functions.6 In addition the presence of ECM molecules in tumour 
microenvironment means the existence of an inflammatory process, which predisposes to 
the acquisition of malignant characteristics for tumour cells.7  
The microenvironment of pre-malignant and early tumour lesions is generally 
composed by immune cells (tumour-infiltrating lymphocytes), such as T lymphocytes, 
macrophages and dendritic cells (DC) – a component of an inflammatory host response. 
The most frequent immune cells within the tumour microenvironment are tumour-
associated macrophages (TAMs) and T cells. TAMs are associated with tumour growth 
and may be pre-requisite for angiogenesis, invasion and metastasis, being correlated with 
poor prognosis. T Cells have both tumour suppressive and promoting effects. In some 
cancers, increased T cell numbers were correlated with better survival and, low levels of T 
cell seem to be associated with more susceptibility to spontaneous or chemical 
carcinogenesis. However, evidence found in solid tumours has showed that many of T 
cells subsets are involved in tumour promotion, progression and metastasis.  
The NK cells are the unique cells without a pro-tumourigenic role.5 In fact; recent 
studies revealed that the presence of NK cells in tumour immune infiltration represents a 
positive prognostic marker.  
 
 
2. NK cells role in innate and adaptive immune system 
The innate system is composed mainly of NK cells, polymorphonucleocytes (PMN) 
and macrophages, and is most directly involved in tumour immunology. These cells also 
participate in the adaptive response and form an important and vital bridge between the 
two arms of the immune system. It recognizes non-self molecules according to a specific 
pattern. Another feature of the innate immune system is the complement, a group of 
inactive proteins in the blood which are activated in the presence of pathogens and 
non-self cells and cause cell lysis.9 
As effectors members of the innate immunity, NK cells play a major role in 
anti-infection activity and tumour surveillance. NK cells can directly kill target cells to 
which they are capable of adhering within 1 to 4 hours without prior activation, priming or 
assistance by cytokines. NK cells can be triggered through various receptors depending 
on specific ligands presented by target cells in a given encounter. 
 
NK cells have been recognized as major producers of cytokines in many 
physiological and pathological conditions, such as IFNγ, tumour necrosis factor (TNF) 
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and interleucine (IL)-10, as well as growth factors such as granulocyte macrophage 
colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and 
IL3. NK cells also secrete several chemokines, which are vital for their co-localization with 
other hematopoietic cells such as DC in areas of inflammation. The production of IFNγ  is 
related with the modulation of T cell responses in lymph nodes, possibly by a direct 
interaction between naïve T cells and NK cells migrating from inflamed peripheral tissues 
to secondary lymphoid compartments and by indirect effect on DC, promoting the 
maturation of DC by NK cell-derived IFNγ  and TNF and subsequently leading to the 
enhancement of antigen presentation to T cells. 
In resume, NK cells modulate emerging B and T cells and are also regulatory cells 
engaged in reciprocal interactions with DCs, macrophages, T cells and endothelial cells. 
Thus NK cells are able to limit or exacerbate immune responses (Figure 2).9 
 
 
 
Figure 2: The biological functions of NK cells.  
DC – dendritic cells. M - Macrophages. Extracted from Vivier et al, 2011
9
 
 
In order to exert effectively their functions, cytolytic and regulatory function of the 
adaptive immune response, NK cells must be recruited to the site of infection or tumour 
and must be in closely proximity to antigen-stimulated T and/or B cells, respectively. They 
require triggering by several factors, such as IL15 presented by DC or macrophages, IL12 
or IL18. IL 15 is an important for the maturation and survival of NK cells. 
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NK cells possess three main groups of receptors: the activating receptors, the 
inhibitory receptors and the chemotactic receptors (Figure 3). Among the activating 
receptors groups are included receptors that interact with cytokines (e.g. NKp46, CD16, 
NKG2D) and receptors that interact with cell surface molecules (e.g. FcRγ). This 
repertoire of receptors allows NK cells to exert their functions through various means: they 
can kill a variety of target cells in the absence of antibody; NK cells are able to detect 
antibody-coated cells through CD16 cell surface receptor and to exert antibody-dependent 
cell cytotoxicity (ADCC) and cytokine production. The natural cytotoxicity receptors, 
NKp46/NCR1; NKp44/NCR2 and NKp30/NCR3, play a crucial role in antitumoral 
responses. 
The activating receptor NKG2D is responsible for the NK cells capacity to 
distinguish self molecules in conditions of cellular stress. This receptor interacts with 
various ligands that have low levels of expression in most tissues but are over-expressed 
in situations of cellular distress. 
 
Figure 3: NK cells receptors. 
Extracted from Vivier et al, 2011
65
 
 
Another function attributed to NK cells is that they are able to detect the lack of 
major histocompatibility complex (MHC) class I (“missing self”), a situation that occurs 
during viral infections or cellular transformation (Figure 4). This is the reason why NK cells 
selectively kill target cells “in distress” and spare healthy cells. This is explained by the 
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expression on the NK cell surface of several MHC class I-specific inhibitory receptors, 
such as killer cell immunoglobulin-like receptors (KIRs) and CD94/NKG2D.  
The array of receptors that individual NK cells express during development is 
largely random, therefore, some NK cells may express activating receptors for a 
self-ligand, but they do not express inhibitory receptors for self-MHC molecules. Thus NK 
cells, like T and B cells, have the potential for auto-reactivity. In order to avoid 
auto-reactivity, such NK cells acquire a state of hypo-responsiveness to self cells and also 
to several other stimuli, including MHC class I-deficient tumour cells or cross-linking 
antibodies specific activating receptors. The findings of several studies leads to the 
suggestion that in steady-state conditions, NK cell tuning enables NK cells with inhibitory 
receptors for self-MHC to rapidly eliminate MHC class I-deficient cells that arise in the 
environment, whereas NK cells with fewer such receptors can be mobilized by 
inflammatory signals that accompany pathogen infections. 
The molecular mechanisms that govern responsiveness are yet not established, 
although it has been suggested that in the presence of high levels of activating ligands, a 
negative turning effect may occur (Figure 5). It has been proposed some possible 
mechanisms for the impaired responsiveness of NK cells: (1) the induction of an anergic 
state in NK cells that are not inhibited by MHC molecules, as can occur in auto-reactive T 
and B cells; (2) the failure of these NK cells to undergo functional maturation, which may 
depend on interactions between MHC and inhibitory receptors on NK cells; (3) the 
function of inhibitory receptors for non-MHC ligands or (4) the action of suppressor cells. 
 
Figure 4: The dynamic regulation of NK cell effector function. NK cells sense the 
density of various cell surface molecules expressed at the surface of interacting cells. The 
integration of these distinct signals dictates the quality and the intensity of the NK cell 
response. NK cells spare healthy cells that express self-MHC class I molecules and low 
amounts of stress-induced self molecules (A), whereas they selectively kill target cells “in 
distress” that down-regulate MHC class I molecules (B) or up-regulate stress-induced self 
molecules (c). + activating receptors; - inhibitory receptors. Extracted from Vivier et al, 2011
9
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Figure 5: NK cell tuning. Schematic experimental conditions in which NK 
cells show to adapt to their environment. In the absence of detection of MHC 
class I (lack of MHC class I receptors) (A), or in MHC class I deficient hosts (B), NK cells 
are hypo-responsive at steady state. NK cells are rendered “anergic” by the chronic 
engagement of various activating receptors such as NKG2D (C), Ly49H in the mouse 
(D) or KIR2DS1 in humans (E). NK cells can be educated by MHC class I molecules via 
their cognate inhibitory receptors (F) and primed by cytokines (G). Extracted from Vivier 
et al, 2011
9 
 
 
 
NK cells Subsets 
The NK cells are lymphogranular cells having an ability to kill the intruding 
pathogens and are the most important cells of the system. They are found in the innate 
and the adaptive system as well. NK cells originate from the lymphoid progenitor and 
migrate to the secondary lymphoid tissues. When activated, NK cells burst forth from the 
tonsils, lymph nodes and spleen, and destroy infected and cancerous cells while the 
immune T and B cells are still mobilizing. They do not require memory from previous 
encounter and target virus infected cells and tumour cells and are the first line of defence.  
Activity of the immune cells varies from person to person and may be genetically 
inherited. The ability to kill cancers cells in less than 24 hours varies from 97% to 2%.10 
NK cells have the ability to kill infected target cells and tumour cells and, also, to secrete 
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various effectors molecules. The physiological functions of NK cells are tightly regulated 
by a delicate balance between signals transmitted by activating and inhibitory receptors.  
 
Human peripheral blood NK (pbNK) cells can be divided into two subsets based on 
their cell surface density of CD56 and CD16, the CD56dim and CD56bright subpopulations13. 
The majority of peripheral blood NK cells, about 90%, is the CD56dim subset, which 
have low density expression of CD56 and express high levels of CD16 and has been 
shown to be responsible for the natural cytotoxicity against tumour targets.  
CD56bright NK cells, comprising 10% of NK cells, expresses high levels of CD56 
and low levels of CD16. CD56bright NK cells secrete higher levels of different cytokines 
such as IFNγ , TNFβ, GM-CSF, IL-10 and IL-13 in response to monokine stimulation. 
CD56bright NK cells exhibit low natural cytotoxicity and ADCC, but have potent 
lymphokine-activated killer (LAK) activity, representing the immunoregulatory subset. 
CD56bright NK cells are able to regulate adaptive T and B cell responses in secondary 
lymphoid tissues.11 
CD56dim NK cells are associated with low capacity to produce cytokines, are potent 
mediators of ADCC, LAK activity and natural cytotoxicity and have a more granular 
morphology than CD56bright NK cells.12 A recent study suggest that CD56dim CD16+NK cells 
also have their unique abilities in influencing events occurring in their microenvironment.14 
 
Moreover, the two NK cell subsets can be distinguished concerning their receptor 
expression profiles (Figure 6). The CD56bright NK cell subset expresses high levels of 
CD94/NKG2A and low levels of killer Ig-like receptors (KIRs), high amounts of chemokine 
receptor 7 (CCR7) and L-selectin (CD62L). The expression of CCR7 and L-selectin 
seems to be responsible for their mobilization to secondary lymphoid tissues. The CD56dim 
NK cells subset show no expression of CCR7 and little or no L-selectin, but high levels of 
another adhesion molecule – PEN5P-selectin glycoprotein ligand-1(PSGL-1), suggesting 
that they migrate to peripheral nonlymphoid tissues. Although, after their activation at sites 
of inflammation in the peripheral tissues, CD56dim NK cells express CCR7, promoting their 
migration to secondary lymphoid tissues.11,13 CD56dim NK cells also have high level 
expression of KIRs15 
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Figure 6: NK cells subsets and surface receptors: NKbright (a) and NKdim (b). 
Extracted from Cooper 2001
13
 
 
As previously described, they exist in both activator and inhibitory forms, and are 
grouped in three major superfamilies: (1) the killer cell Ig-like receptor (KIR) superfamily, 
(2) the C-type lectin superfamily (CD94, NKG2 receptors); and (3) natural cytotoxicity 
receptors (NCRs). Another class of NK’ receptors have been described, the Ig-like 
transcripts (ILTs). NK receptors (NKRs) are crucial for distinguishing normal cells from 
infected and/or transformed cells by monitoring the expression levels of MHC molecules.12 
Opposite to CD56dim NK cell, CD56bright NK cells have low or no expression of KIRs 
and ILT-2 (an inhibitory receptor) and high level expression of CD94-NKG2A inhibitory 
receptors. 
Both NK cells subsets, as well as T cells, macrophages and CD8+ T cells, largely 
express the activating NKG2D receptor, which has the capacity to interact with a diverse 
family of MHC class I-related ligands that are induced by cellular stress.16 
KIRs control the response of NK cells by delivering inhibitory or activating signals 
upon recognition of MHC class I ligands on the surface of target cells. They provide an 
alternative means of modulating the immune response to damaged or foreign cells.16 
The NCRs are exclusively expressed on NK cells and appear to be the main 
receptors involved in antitumoral responses. 
 
Relatively to NK maturation, Yu et al17 suggested that the density of CD94 surface 
expression on CD56dim NK cells identifies a functional and developmental intermediary 
between CD56bright and CD94lowCD56dim NK cells, and that CD56bright NK cells progress 
through a continuum of differentiation that ends with CD94lowCD56dim phenotype. 13 
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3. NK cells in cancer immunity 
Several studies verified that the lack of NK cells or molecules associated with NK 
cells recognition or effectors function in mice was associated with an increase of tumour 
incidence. In another studies the loss of immune competence, more precisely the low 
levels of NK cells, is considered an important cancer risk factor and allows to conclude 
that NK cells participates in immunosurveillence against certain types of tumours.3 
The NK cells act in tumour immunosurveillance (Figure 7), by directly inducing 
tumour cells death (NK act as cytolytic effectors lymphocytes), even with the absence of 
surface adhesion molecules and antigenic peptides.4,9 NK cells initially recognize certain 
‘stress’ or ‘danger’ signals that are produced by tumours. NK-cell lysis of cancer cells 
could provide tumour antigens for DCs, which induce them to mature and present antigen 
to CTLs in lymph nodes. Cytokines, such as IFNγ , produced by activated NK cells, 
activate CTL and helper T-cell (CD4+) responses. This leads to the proliferation of helper 
T cells and cytokine production. Activated NKT cells can also induce the antitumour 
activity of NK cells. Cytokines that are produced by NK cells might also regulate B-cell 
production of antitumour antibodies. 18 
 
 
Figure 7: Schematic presentation of NK role in immunoediting theory.  
Extracted from Smyth et al.18 
 
According to the immunoediting theory cancer cells and immune cells reciprocally 
modulate each other and the two possible outcomes are: the elimination or escape of 
             Effect of Acupuncture on NK cells in CRC patients undergoing chemotherapy                                                   
Irene Pais   12 
tumour cells. NK cells are considered to represent a first line of defence against the 
metastatic spread of tumour cells. This idea is supported by the report of an association 
between the decreased activity or low numbers of circulating NK cells with progression of 
cancers; and a correlation between an absolute decrease in the activity of the NK cells 
and an absolute decrease in the lytic potential of these cells.19 Recent studies of 
tumour-associated NK cells demonstrated a striking phenotype, supporting the notion that 
tumour-induced alterations of activating NK cell receptor expression may hamper immune 
surveillance and promote tumour progression. These tumour-induced alterations includes, 
in some cases the down-regulation of activating receptors and in others, the 
over-expression of inhibitory receptors leading to reduced cytotoxicity. 
Studies in metastatic melanoma patients reveal decreased activity and IFN 
production of NK cells and a redistribution of NK subsets: an increase of non-cytotoxic NK 
(CD56bright) cells and a decrease of cytotoxic NK cells (CD56dim). Additionally, they found a 
decreased NKG2D activating receptor and an over-expressed inhibitory NK cell receptor 
(CD158a), which is correlated to lower NK cell cytotoxicity.20 
 
 
4. Co-stimulatory molecules that regulate NK-cell antitumour immunity and link 
innate and acquired immune system  
NK cells and DCs have the ability to reciprocally activate one-another, through two 
possible distinct mechanisms: (1) cell contact involving unknown receptor-ligand pairs and 
(2) through soluble mediators produced by the two cells. The cytokines, TNF, IL-2, IL-12, 
IL-18 and IFNγ, have all been implicated in this process. The end result of these 
interactions is NK cells activated for cytotoxicity, IFNγ production, and proliferation and 
DC that have matured and are capable of cytokine production and T cell activation 
(Figure 8).21 
NK cells can be activated by tumour-cell- or DC-surface molecules, such as CD70, 
CD80 or CD86. Activated NK cells proliferate and produce cytokines such as IFNγ, or kill 
the tumour cell or DC. IFNγ  that is produced by activated NK cells can promote (a) the 
antitumor acquired immune response, inducing the CD8+T cells to become 
antigen-specific CTLs, which lead to the development of immunological memory against 
the tumour; and (b) promote differentiation of CD4+T cells towards a Th1-dominant state 
which promotes CTL differentiation. NK-cell activation following DC-NK-cell interaction 
can also result in DC maturation. These DCs can facilitate the generation of CD8+T-cell 
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responses through their ability to internalize and present T cells with tumour-specific 
antigens, which were derived from NK-cell-mediated tumour-cell lysis. 18 
 
Figure 8. Role of CD56bright NK cells and T cell in the interaction between adaptive 
and innate system. Extracted from Smyth et al.18 
 
 
Todd et al,22 demonstrate that CD56bright NK cells and T cell are crucial cells in the 
interaction between adaptive and innate system. They found that endogenous T 
cell-derived IL-2, acting through the high affinity IL-2 receptor, co-stimulates CD56bright NK 
cells to secrete IFNγ. 
 
 
5. Immune parameters affecting the efficacy of chemotherapy regimens  
The outcome of chemotherapy can be influenced by the host immune system at 
multiple levels. Chemotherapy can kill cancer cells by causing them to elicit an immune 
response or alternatively, by increasing their susceptibility to immune attack. In addition, 
chemotherapy can stimulate anticancer immune effectors either in a direct fashion or by 
subverting immunosuppressive mechanisms. Beyond cancer-cell-intrinsic factors that 
determine the cytotoxic or cytostatic response, as well as the potential immunogenicity of 
tumour cells, the functional state of the host immune system has a major prognostic and 
predictive impact on the fate of cancer patients treated with conventional or targeted 
chemotherapies.23 
It was supposed that chemotherapeutic agents elicit immunogenic tumour cell-
death and the release of immunogenic signals. These signals are recognized by innate 
immune effectors (DCs) and trigger an adaptive immune response, which includes CD8+ T 
cells and IFNγ signalling, and allows the immune system to control residual tumour cells. 
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Assuming this supposition as real, the interruption of this pathway at any level would lead 
to therapeutic failure: (1) chemotherapeutic agent may be unable to trigger immunogenic 
cell death; (2) tumour cells may be unable to express the required set of immunogenic 
signals; (3) the innate immune system may be unable to recognize such immunogenic 
signals; and (4) local or systemic immunosuppression or tumour-dependent 
immunosubversion and immunoevasion can prevent the formation, recruitment or action 
of adaptive immune effectors.23 
Studies performed in multiple human carcinomas suggest that DCs, M1 
macrophages, cytotoxic CD8+ T cells, Th1 CD4+ T cells, NK cells and Th1 CD4+ T cells 
present in the tumour bed possibly reduce cancer growth. And by contrast, neutrophils, 
M2 macrophages, myeloid-derived suppressor cells, Th2 CD4+ T cells, B lymphocytes are 
suspected to stimulate cancer growth. 
 
 
6. The immune system and the quality of life (QOL) in cancer patients 
Cancer diagnosis is a significant source of anxiety, depression and emotional 
distress, followed by an extended period of stressful cancer treatment significantly 
compromise patients’ QOL. About 20-40% of cancer patients exhibit significant levels of 
depression and anxiety, which was associated with higher frequency and severity of 
clinical symptoms, such as pain, fatigue, poor appetite, sleep disturbance and poor quality 
of life.24 
Psychological stress may have multiple negative impacts on health outcomes, 
namely with a) higher incidence of infections, accelerated aging, and greater 
cardiovascular diseases in several populations; b) in breast cancer patients, with low 
physical and psychological QOL and significantly shorter disease-free interval; and with 
(3) a decrease of efficacy or resistance to chemotherapeutics agents, in animal models. 
According to psychoneuroimmunology, psychological and emotional stress 
induces several alterations in diverse biological responses. The activation of the 
hypothalamic-pituitary-adrenal axis and the sympathetic nervous system may generate a 
change in the immune cell traffics and promotes inflammation via multiple neuroendocrine 
and immune pathways. Higher stress levels were associated with poorer immune 
responses (low NK cell activity) and the stress reduction with improvement of immune 
responses, in women with breast cancer. Furthermore, psychological and emotional 
stress has negative implications for increased symptom perception and poor quality of life, 
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and is significantly associated with increased neutrophil percentage but decreased 
lymphocyte percentage which has been associated with negative cancer outcomes.24 
A study on early stage breast and prostate cancer found an association between 
the reduction of stress levels and the depressive pattern with a shift in the balance from a 
pro-inflammatory to an anti-inflammatory environment.25 
WHO defines Quality of Life as individuals’ perception of their position in life in 
the context of the culture and value systems in which they live and in relation to their 
goals, expectations, standards and concerns. It is a broad ranging concept affected in a 
complex way by the person's physical health, psychological state, level of independence, 
social relationships, personal beliefs and their relationship to salient features of their 
environment. 
The effect that chemotherapy may have on QOL is extremely important. This QOL 
includes not only the individual's physical well-being, but their mental well-being, role 
functioning and levels of emotional distress as well. 
The inclusion of QOL endpoints in chemotherapy trials with cancer patients started 
in earliest during the last decade, with the majority of studies assessing the impact of 
chemotherapeutic agents on symptoms such as pain and fatigue. Since then, the 
inclusion of QOL endpoints has become a more common outcome in chemotherapy 
studies, although many continue to neglect the psychological component, focusing instead 
on the occurrence of symptoms and their impact on physical QOL.  
QOL may be considered to be the effect of an illness and its treatment as 
perceived by patients and is modified by factors such as impairments, functional stress, 
perceptions and social opportunities.26 
The most widely applicable instrument to measure the QOL in cancer patients is 
the EORTC QLQ-C30. 
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1. Epidemiology and Etiopathophysiology 
Colorectal cancer (CRC) is the fourth leading cause of cancer deaths worldwide in 
both men and women.27 Approximately two thirds of the cases are located in the colon.  
The disease is often considered as one, irrespective of location, but should 
probably be regarded as two distinct entities as biology, risk factors, treatment and 
outcome may differ.28,29 Most CRCs (95%) are epithelial cancers (adenocarcinoma) that 
originate from glandular tissue. Other, rarer cancers in the colon and rectum are 
squamous cell carcinoma and lymphoma. 
In Portugal, CRC is the second most common cancer among Portuguese men and 
women, with an incidence rate of 40.6 and 24.1 cases per 100,000, respectively and with 
a mortality rate of 19.6 and 16.4 per 100,000, respectively. 30 
In respect to CRC mortality in Europe, Portugal is the 8th country with highest 
mortality indexes, and the male rates higher than female rates; Hungary accounts with the 
highest mortality rates for both sexes and Greece and Cyprus accounts with the lowest 
rates.31  
 
The development of CRC has been associated with several important risk factors, 
which can be aggregated in two main groups: the “environmental” factors group and 
the genetics factors group.32  
The findings from epidemiologic studies that physical inactivity, excess of body 
weight and a central accumulation of adiposity have influence on CRC risk, as well as the 
ethnic and racial differences in CRC and studies on migrants suggest that an 
environmental factor plays an important role in aetiology of this disease. In fact, diet is 
considered an important factor of increased risk in the development of CRC, playing a 
significant role in determining the incidence of CRC in the general population. Compelling 
evidence suggests a strong dose-related association between red meat and fat intake and 
the development of CRC; and higher cholesterol values correlates significantly with later 
tumour development. On the other hand, diets rich in vegetables and high fibber grains as 
well as the consumption of fish and skinless chicken demonstrate a protective effect in the 
pathophysiology of CRC.  
In fact, the modifiable lifestyle factors are thought to contribute substantially to the 
geographical difference in CRC incidence33.  
Mutations in the genes Kras and p53 are highly relevant for CRC development 
and the same mutations have been linked to reduced physical activity, smoking and diets 
high in red meat.34  
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Regular exercise may increase the number and activity of macrophages, natural 
killer cells, and cytokines with the ability to kill cancer cells and thereby improve anti-
tumour immune responses.35 Furthermore, obesity may be a risk factor for CRC 
development independently of inactivity. Visceral adiposity is associated with low-grade 
chronic inflammation leading to up-regulation of the nuclear transcription factor-Kβ (NF-
Kβ) with transcription of genes that promote tumourigenesis as a consequence.36 
Prostaglandin E2 (PGE2) is reduced with high levels of physical activity, possibly through 
insulin-like growth factor-1 (IGF-1)37 and PGE2 affects both tumour immunity and 
tumourigenesis.38 The motility of the intestine may affect CRC risk as shortened intestinal 
transit time reduces the exposure of the mucosa to faecal carcinogens. Exercise is 
thought to increase the expression of PGF2 and the vagal tone, both stimulating motility. 
Diets high in fiber, fresh fruits and fresh vegetables may also shorten the intestinal transit 
time and the formation of fiber may produce mucosa-protecting agents, thereby affecting 
CRC risk. However, studies regarding diet, transit time and CRC risk are contradictory 
and firm conclusions cannot be drawn.39,40,41,42 
Insulin and IGF-1 are up-regulated in the absence of physical activity and in 
obesity.51 Increased levels of insulin and IFG-1 are correlated with risk of CRC 52 possibly 
through mechanisms that activate the Wnt pathway and increase the expression of pro-
angiogenic proteins such as HIF-11 and vascular endothelial growth factor (VEGF).36 
Furthermore, elevated levels of the reciprocally expressed insulin-like growth factor-
binding protein-3 (IGFBP-3) have been shown to be associated with reduced risk of 
CRC.53 
 
Increasing age43 and a family history of CRC44 predispose to the development of 
CRC, and CRC is slightly more common in men. Furthermore, genetic conditions such 
as familial adenomatous polyposis (FAP)45, Lynch syndrome (formerly HNPCC; hereditary 
nonpolyposis colorectal cancer)46 and Gardner’s syndrome (considered a subtype of 
FAP)47are genetic risk factors. The FAP syndrome accounts for approximately 1% of all 
CRC cases and patients will most likely present with adenocarcinoma before the age of 
40. Therefore, prophylactic colectomy is recommended at an early age for FAP patients.48 
Gardner’s syndrome is a rare phenotypic variant of FAP, both caused by mutation 
in the APC gene. In addition to colon polyposis, Gardner patients acquire extra-colonic 
tumours including osteomas, thyroid cancer, epidermoid cysts, fibromas, sebaceous cysts 
and desmoids tumours 47. The disease is not curable and life expectancy with the 
condition is 35-45 years.  
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Lynch syndrome is an autossomal dominant trait (as FAP) predisposing for CRC, 
the associated mutations impair genes related to DNA mismatch repair. Approximately 1 
to 4% of the cases of colon cancer are related to Lynch syndrome.46 
Patients with inflammatory bowel disease (IBD; ulcerative colitis and Crohn’s) 
disease have increased risk of developing CRC and the risk is more likely a result of 
chronic inflammation rather than genetic predisposition.49 The progression from adenoma 
to carcinoma that occurs during development of sporadic colorectal tumours appears to 
be a sequence of inflammation – dysplasia – carcinoma in IBD-associated CRC49. Primary 
sclerosing cholangitis (PSC) is another chronic inflammatory disease associated with 
CRC when concomitant with IBD.50 Pro-inflammatory factors of the innate and adaptive 
immune system contributes to the development and growth of colon neoplasia. 
 
It is too early to establish a causal relationship between smoking and CRC, 
however most reports point in the direction that smoking is a risk factor.51,54 Furthermore, 
smoking may be associated with different subtypes with different mutational background 
than non-smokers (e.g. p53, APC and Kras).55 Heavy alcohol intake (>45g/day) has been 
associated with increased risk of CRC, while lower levels were not.56 The increased CRC 
risk has been suggested to be associated with lower intake of folate connected with heavy 
drinking.57 
In conclusion, there is evidence that inactivity, red meat, smoking, alcohol, and 
obesity are connected to increased risk of CRC, but the quality of the observations varies 
and in some cases, there are contradictory reports. 
 
 
1.1. Clinical presentation  
Patients with CRC may present in three ways: patients with suspicious symptoms 
and/or signs; asymptomatic individuals discovered by routine screening; and emergency 
admission with intestinal obstruction, peritonitis, or rarely, an acute gastrointestinal bleed. 
Despite the increasing usage of CRC screening allows the early diagnosis, on an 
asymptomatic, of CRC, the majority of CRCs is diagnosed after the occurrence of 
symptoms. The symptomatic presentation of CRC is normally due to growth of the tumour 
into the lumen or adjacent structures and usually reflects relatively advanced CRC. The 
symptomatic presentation can be divided in two groups: symptoms that derive from the 
local tumour and symptoms related to metastasis.58 
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Symptoms/signs associated with local CRC include hematochezia or melena, 
abdominal pain, otherwise unexplained iron deficiency anemia, and/or a change in bowel 
habits. Abdominal distention, and/or nausea and vomiting, which may be indicators of 
obstruction, are less common presenting symptoms. Obstructive symptoms are more 
common with cancers that encircle the bowel, producing the so-called "apple-core" (seen 
on radiologic imaging). Rectal cancer can also cause also cause tenesmus, rectal pain, 
and diminished caliber of stools. 
These clinical manifestations differ according on tumour location: a change in 
bowel habits is generally indicator of left-sided than right-sided CRCs because fecal 
contents are liquid in the proximal colon and the lumen caliber is larger, and they are 
therefore less likely to be associated with obstructive symptoms; Hematochezia is more 
often caused by rectosigmoid than right-sided colon cancer; Iron deficiency anemia is 
more common with right-sided CRCs. Cecal and ascending colon tumors have a fourfold 
higher mean daily blood loss (approximately 9 mL/day) than tumors at other colonic sites. 
Abdominal pain can occur with tumors arising at all sites; it can be caused by a 
partial obstruction, peritoneal dissemination, or intestinal perforation leading to 
generalized peritonitis.  
The symptoms/signs of metastatic disease include the presence of right upper 
quadrant pain, abdominal distention, early satiety, supraclavicular adenopathy, or 
periumbilical nodules. These categories of symptoms are explained by de fact that the 
most common metastatic sites are regional lymph nodes, liver, lungs and peritoneum. 
Since the venous drainage of the intestinal tract is via the portal system, the first site of 
hematogenous dissemination is generally the liver, followed by the lungs, bone, and many 
other sites, including the brain. However, tumors arising in the distal rectum may 
metastasize initially to the lungs because the inferior rectal vein drains into the inferior 
vena cava rather than into the portal venous system. 
 
There are also a diversity of atypical presentations of CRC, including: a) local 
invasion or a contained perforation causing malignant fistula formation into adjacent 
organs, such as bladder (resulting in pneumaturia) or small bowel; b) Fever of unknown 
origin, the existence of abscesses (intra abdominal, retroperitoneal, abdominal wall or 
intrahepatic) due to a localized perforated colon cancer; c) Streptococcus bovis 
bacteremia and Clostridium septicum sepsis are associated with underlying colonic 
malignancies in about 10% to 25% of patients. Seldom, other extra-abdominal infections 
caused by colonic anaerobic organisms (eg, Bacteroides fragilis) may be associated with 
CRC.  
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The presence of symptoms and their particular type provide some prognostic 
importance: symptomatic patients at time of diagnosis have a more advanced disease and 
a worse prognosis; however, asymptomatic patients tend to have a more favorable 
pathological stage and consequently better prognosis. 
1.2 Diagnosis 
CRC may be suspected from one or more of the symptoms and signs described 
above or may be asymptomatic and discovered by routine screening of average and high-
risk subjects. Once a CRC is suspected, the next test can be a colonoscopy, barium 
enema, or CT colonography. However, examination of tissue is required to establish the 
diagnosis; this is usually accomplished by colonoscopy. In fact, colonoscopy is the most 
accurate and resourceful diagnostic test for CRC, since it can localize and biopsy lesions 
throughout the large bowel, detect synchronous neoplasm, and remove polyps. 
Synchronous CRCs, refers to the diagnosis, within six months of an initial CRC, of two or 
more distinct primary tumors, separated by normal bowel, and not due to direct extension 
or metastasis. 
The vast majority of colon and rectal cancers are endoluminal masses (exophytic 
or polypoid) that arise from the mucosa and protrude into the lumen. Bleeding may be 
seen with lesions that are friable, necrotic, or ulcerated. Circumferential or 
near-circumferential involvement of the bowel wall correlates with the so-called "apple-
core" description seen on radiologic imaging.  
 
 
Figure 9. Colonic features and corresponding barium enema X-rays.  
A: carcinoma in the cecum; B: pedunculated polyp; C: apple core lesion. 
From: http://www.hopkinscoloncancercenter.org 
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A minority of neoplastic lesions in the gastrointestinal tract is nonpolypoid and 
relatively flat or depressed, which are more difficult to detect by colonoscopy. 
If a malignant obstruction precludes a full colonoscopy preoperatively, the entire 
residual colon should be examined soon after resection.  
Flexible sigmoidoscopy is generally not considered to be an adequate diagnostic 
study for a patient suspected of having a CRC, unless a palpable mass is felt in the 
rectum. In such cases, a full colonoscopy will still be needed to evaluate the remainder of 
the colon for synchronous polyps and cancers.  
Barium enema is widely available and may be used to investigate patients with 
symptoms suggesting of CRC. However, the diagnostic yield of both double-contrast 
barium enema (DCBE) alone and the combination of DCBE plus flexible sigmoidoscopy is 
less than that of colonoscopy or CT colonography for the evaluation of lower tract 
symptoms. After detection by barium enema of a polyp or a mass, colonoscopy is 
recommended to establish the histology, remove the polyp, and search for synchronous 
lesions.  
CT colonography (virtual colonoscopy or CT colography) provides a computer-
simulated endoluminal perspective of the air-filled distended colon. CT colonography 
requires a mechanical bowel preparation that is similar to that needed for barium enema, 
since stool can simulate polyps.  
Reasons for incompleteness include the inability of the colonoscope to reach the 
tumour or to visualize the mucosa proximal to the tumour for technical reasons (eg, 
partially or completely obstructing cancer, tortuous colon, and poor preparation) and 
patient intolerance of the examination. CT colonography should be restricted to patients 
who are able to pass flatus and capable of tolerating the oral preparation. For clinically 
obstructed patients, a gastrointestinal (GI) CT scan is a good alternative to CT 
colonography.  
Resuming, the CT colonography provides a similarly sensitive, less invasive 
alternative to colonoscopy in patients presenting with symptoms suggestive of CRC. 
However, since colonoscopy permits removal/biopsy of the lesion and the detection of any 
synchronous cancers or polyps, colonoscopy seems to constitute the gold standard for 
investigation of symptoms suggestive of CRC.  
 
In respect to laboratory tests, although CRC is often associated with iron 
deficiency anemia, its absence does not reliably exclude the disease. There is no 
diagnostic role for other routine laboratory test, including liver function tests, which lack 
sensitivity for detection of liver metastases. 
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A variety of serum markers have been associated with CRC, particularly 
carcinoembryonic antigen (CEA). However, all these markers have a low diagnostic ability 
to detect primary CRC due low sensitivity for early stage disease. And on other hand, non-
cancer-related causes can elevate CEA levels, including gastritis, peptic ulcer disease, 
diverticulitis, liver disease, chronic obstructive pulmonary disease, diabetes, and any 
acute or chronic inflammatory state. The American Society of Clinical Oncology (ASCO) 
and the European Group on Tumour Markers recommended that neither serum CEA nor 
CA 19.9 levels should be used as a screening or diagnostic test for colorectal cancer.  
However, CEA levels do have value in the follow-up of patients with diagnosed 
CRC as well as on preoperative scenarios with the objective to aid in surgical treatment 
planning, post-treatment follow up, and in the assessment of prognosis: CEA >5 ng/mL 
have a worse prognosis, stage for stage, than those with lower levels; and elevated 
preoperative CEA levels that do not normalize following surgical resection imply the 
presence of persistent disease and the need for further evaluation.  
Furthermore it’s recommended to perform a serial assay of postoperative CEA 
levels for five years for patients with stage II and III disease candidate for surgery or 
chemotherapy (metastatic disease). A rising CEA level after surgical resection implies 
recurrent disease and should prompt follow-up radiologic imaging.58 
 
1.3 CRC Staging 
Two different staging systems are used to provide prognostic information and 
determine treatment strategy in CRC. The Duke classification system from 1932 59 has 
been replaced by the more detailed TNM staging system developed and maintained by 
the American Joint Committee on Cancer (AJCC). Duke staging is no longer 
recommended for use in clinical practice and is not further discussed here. TNM staging 
(tumour, node and metastasis) is used on many solid cancers, adapted for CRC and is 
now in the 7th edition as of 2010. As Table I shows, the tumour is first scored with respect 
to the TNM variables then assigned to stage I-IV in the CRC specific (Table II). However, 
TNM does not adapt to recent advances in metastatic treatment. For example, the survival 
of a patient with resectable solitary liver metastasis is better than that of a patient with 
stage III disease.60 Current observations regarding the clinical course of the patients with 
CRLM support emerging arguments for a new staging system in CRC. 60,61,62 
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TMN Stages Disease extension 
T – Primary Tumour 
Tx 
T0 
Tis 
 
T1 
T2 
T3 
 
T4 
 
 
primary tumour cannot be assessed 
no evidence of primary tumour 
carcinoma in situ: intraepithelial or invasion of lamina propria 
tumour invades submucosa 
tumour invades muscularis propria  
tumour invades through muscularis propria into subserosa or 
into nonperitonealized pericolic or perirectal tissues  
tumour directly invades other organs or structures and/or 
perforates visceral peritoneum 
N – Regional Lymph 
Nodes 
Nx 
N0 
N1 
N2 
 
 
Regional lymph nodes cannot be assessed 
No regional lymph node metastasis 
Metastasis in one to three regional lymph nodes 
Metastasis in four or more regional lymph nodes 
M – Distant Metastasis 
Mx 
M0 
M1 
 
Distant metastasis cannot be assessed 
No distant metastasis 
Distant metastasis 
Table 1. The 7th edition of AJCC-TNM classification system. 
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Stages T N M 
0 Tis N0 M0 
 
I 
T1 N0 M0 
T2 N0 M0 
 
II 
T3 N0 M0 
T4 N0 M0 
 
III 
T1, T2 N1 or N2 M0 
T3, T4 N1 or N2 M0 
IV Any T Any N M1 
Table 2. The 7th Edition of AJCC-TNM Classification System. 
 
 
 
In respect to rectal cancer, the TNM staging should be used, being recommended 
the version 5 from 1997 over TNM version 6 (2002) and 7 (2010), due to marked 
interobserver variation in defining stage II and Stage II, on the version 7. And also, there is 
the need for further subclassification particularly of cT3 (Table 3).63 
T1 tumours refer to cancers that are in a stalked adenoma and according to the 
submucosa (sm)-system in a sessile adenoma. The level of infiltration into the submucosa 
predicts the risk of lymph node metastases and thus the type of surgery. 
 
 
 
 
 
 
 
 
 
 
 
 Irene Pais   27 
TNM Stage Extension to 
Tis N0 M0 0 Carcinoma in situ: intraepithelial or invasion of lamina propria 
T1 N0M0 I Submucosa 
T2 N0M0 I Muscularis propria 
T3 N0M0 II A Subserosa/perirectal tissue 
 Substagingª T3a <1 mm 
  T3b 1-5mm 
  T3c 5-15mm 
  T3d >15mm 
T4 N0 M0 II B Perforation into visceral peritoneum (b) or invasion to other 
 organs (a)
b
 
T1-2 N1 M0 III A 1–3 regional nodes involved 
T3-4 N1 M0 III B 1–3 regional nodes involved 
T1-4 N2 M0 III C ‡4 regional nodes involved 
T1-4 N1-2 M1 IV Distant metastases 
Table 3: Rectal cancer. TNM staging. 
a 
Subclassiﬁcation based upon an evaluation using MRI before treatment decision is clinically 
valuable, and used in these recommendations. It can be used also in the histopathological 
classiﬁcation but is not validated and not incorporated in any of the TNM versions (5–7).
b 
This is the 
subclassiﬁcation in TNM5. It has been reversed in TNM6 and 7. 
 
 
2. Treatment management of CRC 
Treatment options vary in accordance with the stage of the cancer – its size, 
position in the colon or rectum (Table IV), whether it has spread to other parts of the body, 
and the physical condition of the patient. In general, the treatment options for CRC are 
surgery, radiotherapy, chemotherapy and biological therapy. 64-69 Chemotherapy can be 
administered in different ways. The Systemic chemotherapy uses drugs that are injected 
into a vein or given by mouth. These drugs enter the bloodstream and reach all areas of 
the body. This treatment is useful for cancers that have metastasized. In the Regional 
chemotherapy, drugs are injected directly into an artery leading to a part of the body 
containing a tumour. This approach concentrates the dose of chemotherapy reaching the 
cancer cells. It reduces side effects by limiting the amount reaching the rest of the body.  
Chemotherapy may be used at different times during the treatment of colon or 
rectal cancers. The chemotherapy used after surgery to remove the cancer is known as 
“adjuvant chemotherapy”. Its goal is to prevent the cancer recurrence, by killing the 
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small number of cancer cells that may have been left behind at surgery or that might have 
escaped from the main tumour and settled in other parts of the body. 
For some cancers, chemotherapy is given (sometimes with radiation) before 
surgery in order to reduce the cancer and make surgery easier. This is known as 
“neoadjuvant treatment” and is often used in treating rectal cancer. 
In advanced cancers, chemotherapy can also be used to help reduce tumours and 
relieve symptoms for cancers that have spread to other organs, such as the liver.  
 
Localized disease 
The main treatment is surgery. The goal of surgery is a wide resection of the 
involved segment of bowel together with removal of its lymphatic drainage, and the 
resection should include a segment of colon of at least 5 cm on either side of the tumour, 
although wider margins are often included due to obligatory ligation of the arterial blood 
supply. 
For stage 0 (Tis N0 M0, T1 N0 M0)., the treatment options include: a) local 
excision or simple polypectomy; b) segmentary resection for larger lesions not amenable 
to local excision. 
The laparoscopic colectomy can be safely performed for colon cancer, particularly 
for left-sided cancer, with long-term oncological results similar to those of the conventional 
approach and with some advantages over the conventional approach, such as reduced 
pain, reduced length of hospitalization and reduced duration of ileus. For right-sided 
colonic cancers, the benefit is less obvious since anastomosis must be hand sew which 
requires a laparotomy. 
The treatment of obstructive colorectal cancers consists in one or two stages. The 
two-stages procedures can include previous colostomy followed by colonic resection, or 
Hartmann’s procedure first followed by colostomy closure and anastomosis. The one-
stage procedure consists in subtotal colectomy or ileorectal anastomosis, in selected 
cases, segmental resection after intraoperative colonic lavage. To relieve obstruction from 
rectosigmoid cancer and allow subsequent one-step resection can be used an endoscopic 
stent.64 
Treatment of stage I (T2 N0 M0) tumours consist in a wide surgical resection and 
anastomosis. For stage II (T3 N0 M0, T4 N0 M0) the standard treatment options include: 
a) wide surgical resection and anastomosis; b) after surgery, in high-risk patients adjuvant 
therapy could be considered. And for stage III (any T, N1 M0, any T, N2 M0) the treatment 
options are a) extensive surgical resection and anastomosis; b) after surgery the standard 
treatment is a doublet schedule with oxaliplatin and 5FU/folinic acid (LV) (FOLFOX4 or 
FLOX). 64 
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It have been recommended the surveillance not only of patients at high risk of 
recurrence as well as in early stage, which encompasses: 64 
 History and physical examination and CEA determination are advised every 3 
to 6 months for 3 years and every 6 to 12 months at years 4 and 5 after 
surgery. 
 Colonoscopy must be performed at year 1 and thereafter every 3–5 years 
looking for metachronous adenomas and cancers. 
 CT scan of chest and abdomen every 6 to 12 months for the ﬁrst 3 years can 
be considered in patients who are at higher risk for recurrence. 
 CEUS (contrast enhancement ultrasound scan) could substitute for abdominal 
CT scan. 
 Other laboratory and radiological examinations are of unproven beneﬁt, being 
restricted to patients with suspicious symptoms. 
 
Metastatic CRC 
The majority of patients have metastatic disease that initially is not suitable for 
resection. Therefore it is crucial to distinguish patients in whom the metastases are 
suitable for resection and those with initially unresectable disease and whom the 
metastases can become resectable after a major response to chemotherapy. 65 
 
In unresectable metastatic CRC, the treatment of patients should be considered as 
a continuum of care in which the determination of the goal of the treatment is important: 
prolongation of survival, cure, improving tumour-related symptoms, stopping tumour 
progression and/or maintaining quality of life (QOL). In the last years the outcome of 
patients with metastatic CRC improved with a median survival almost reaching 24 
months.65 
The first line palliative chemotherapy consists of a fluoropyrimidine (intravenous 
5-fluorouracil (5-FU) or oral fluoropyrimidines) in diverse combinations and schedules. 
The most frequently used regimens are a 48h infused regimen of 5-FU/leucovorin (LV) 
every 2 weeks (LV5FU2). The oral fluoropyrimidines capecitabine and uracil-ftorafur 
(UFT/LV) are an alternative to intravenous 5-FU/LV as monotherapy. 65 
 
Another chemotherapy combination can be used with higher response rates, 
longer progression-free survival and better survival than 5-FU/LV, the combination of 
5-FU/LV/oxaliplatin (FOLFOX) or 5-FU/LV/irinotecan (FOLFORI). These two regimens, 
FOLFOX and FOLFORI, have similar activity, but differ on toxicity profile, where irinotecan 
induces more alopecia and diarrhoea and oxaliplatin induces more polyneuropathy. They 
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consist of a 48h administration every 2 weeks. It was showed that combination 
chemotherapy is not superior to sequential treatment in terms of overall survival, thus 
sequential therapy starting with fluoropyrimidine monotherapy is a valid option in selected 
and frail patients. The selection criteria of patients to enrol the monotherapy are not yet 
well establish, but it is estimated that about 15% of patients are treated initially with 
fluoropyrimidine alone. 
 
An alternative to the combination of infused 5-FU and oxaliplatin, based on similar 
activity and safety, is the combination of capecitabine plus oxaliplatin (CAPOX/XELOX). 65 
The duration of chemotherapy for metastatic CRC remains controversial; however, 
options are a fixed treatment period, between 3-6 months, and treatment until progression 
or toxicity. The interruption of treatment or less intensive cytotoxic treatment should be 
considered in cases of cumulative toxicity, of unresectable metastases and if the disease 
is controlled. The maintenance treatment with fluoropyrimidine alone is advisable, 
prolongs the progression-free survival. In cases of tumour progression is indicated the 
reintroduction of combination chemotherapy. 
 
In order to improve the outcome of selected patients with metastatic CRC, 
monoclonal antibodies against VEGF and against epidermal growth factor receptor 
(EGFR) should be considered in combination with chemotherapy. Bevacizumab, an anti-
VEGF antibody, increases the activity of an active cytotoxic regimen, therefore, increases 
the survival, progression-free survival and response rate in first-line treatments. 
The anti-EGFR antibodies cetuximab and panitumumab are active as single agent 
in chemorefractory metastatic CRC. It has been shown that cetuximab improves survival 
of chemorefractory patients and panitumumab improves the progression-free survival. The 
anti-EGFR antibodies activity is confined to Kras wild-type tumours, not being its usage 
indicated in Kras mutant CRC. About 40% of metastatic CRCs are Kras mutant and 5% to 
10% of CRC are BRAF mutant. Kras mutations and BRAF mutations are usually mutually 
exclusive. Thus, the anti-EGFR antibodies seem to be confined to BRAF wild-type CRC.  
In patients presenting synchronously with primary colon cancer and metastases, 
and presenting symptoms of the primary tumour (e.g. occlusion, bleeding), it should be 
considered a resection of the primary tumour before starting chemotherapy. In patients 
with metastatic rectal cancer with symptoms of the primary tumour, it is indicated 
irradiation of the primary tumour, possibly combined with chemotherapy. 
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Resection of metastatic disease 
The surgical resection is indicated for solitary or confined liver metastases, 
providing a 5-year survival rate ranging from 30% -35% to more than 50%. However, 
about 60%-70% of these patients will have a relapse following the resection of the hepatic 
metastases. In patients with resectable metastases, perioperative combination (3 months 
before and 3 months after surgery) chemotherapy with FOLFOX regimen improves the 
progression-free survival by 7%-8% at 3 years. In cases of lung metastases, its resection 
offers 25%-35% 5-year survival rates. 
In patients with initially unresectable metastases, the combination chemotherapy 
regimens of 5-FU/LV in combination with either irinotecan (FOLFORI) or oxaliplatin 
(FOLFOX) seems to facilitate the resection of 7%-40%. However, about 75%-80% of 
these patients will relapse within 2 years of resection. 
 
It is recommended a re-evaluation of the patient every 2-3 months if chemotherapy 
is continued; and during palliative chemotherapy it is recommended CEA evaluation, if 
initially elevated, and a CT scan of the involved regions after 2-3 months, and also the 
evaluation of the general conditions, the side-effects of the chemotherapy and the impact 
on the QOL of the patient and physical examination.64  
 
Rectal cancer 
From a practical point of view influencing treatment, the rectal cancers can be 
divided into four groups: very early (some cT1), early (cT1-2, some cT3), more advanced 
(cT3, some cT4) and locally advanced (cT4).63 Therefore very early cancers normally 
correspond to the malignant polyps, are indicated for a local procedure, using the 
transanal endocopic microsurgery (TEM) technique. In the early tumours, due to the risk 
of recurrence or lymph node metastases is too high (>10%) it is recommended 
postoperative chemoradiotherapy or more safely a major surgery (total mesorectal 
excision-TME). When cancer diagnosis is achieved through a biopsy, a presurgical 
chemoradiotherapy is indicated for perform a local procedure. In more locally advanced 
tumours (most cT3, some cT4) is recommended radiotherapy followed by TME, reducing 
local recurrence rates. Even in the absence of extramural growth (cT2) in very low 
tumours, preoperative radiotherapy may be indicated because the distance to the 
mesorectal fascia is very small. In the most locally advanced, frequently non-resectable 
tumours (cT3, cT4) with overgrowth to organs not readily resectable (cT4a) is indicated 
preoperative radiochemotherapy with concomitant 5-FU, followed by radical surgery 6-8 
weeks later. 
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The combination of radio and neoadjuvant chemotherapy has shown to be more 
efficient in the treatment of resectable rectal cancer, in stages II and III, resulting in lower 
recurrence and higher survival rates, in comparison to single treatments options (surgery 
or radio or chemotherapy).66,69  The most used neoadjuvant chemoradiotherapy is the 
combination of capecitabine and oxaliplatin (XELOX) and radiotherapy. Capecitabine has 
been studied with results that suggest that may be equivalent to continuous infusion of 
5-FU.68 The efficacy of combined adjuvant therapy led to the investigation of effect of 
chemoradiation in the preoperative period and has been demonstrated that the 
combination of neoadjuvant chemoradiation provides better control of the local disease, 
lower toxicity and reducing the need for colostomy compared with patients at stage II or III 
submitted only to the adjuvant treatment. 
Currently, the default schema of the treatment of Rectal Cancer in stages II and III 
is based on the preoperative chemoradiotherapy (XELOX) followed by surgical resection 
and adjuvant chemoradiotherapy (FOLFOX).69 
 
3. Chemotherapy - common used agents and related side effects 
The history of chemotherapy dates from the 20th century, being used to treat 
cancer only in the beginning of 1930. Paul Ehrlich introduced the term “chemotherapy” to 
describe the chemical treatment of disease. Chemotherapy has a great curative potential 
in some types of advanced cancer, such as acute lymphoblastic and acute myelogenous 
leukemia, Hodgkin’s and non-Hodgkin’s lymphoma, germ cell cancer, lung cancer, ovarian 
cancer and choriocarcinoma, among others. However, the curative potential is not always 
observed, nevertheless, it promotes significant improvement in progression-free and 
overall survival.77 
 
The most common types of chemotherapy agents are alkylating agents, 
antimetabolites, taxanes, anthracyclines and platinum based (Table V). 
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Type of agent Mechanism Examples 
Alkylanting Modification of nucleic acid functional 
groups 
Cyclophosphamide, 
dacarbazine 
Antimetabolites 
Nucleoside analogs, alters RNA and 
DNA synthesis 
5-FU, gemcitabine 
Taxanes 
Disruption of microtubule formation, 
blocks cell division 
Paclitaxel, Docetaxel 
Anthracyclines 
Interfere with DNA replication 
process, inhibit RNA and DNA 
synthesis 
Doxorubicin 
Platinum based Cross link DNA Cisplatin, carboplatin, 
oxaliplatin 
Table 4 Common types of chemotherapy agents and their mechanisms. 
 
The side effects of chemotherapy depend on the type and dose of drugs given 
and the length of time they are taken. Common side effects drugs can include hair loss, 
mouth sores, loss of appetite, nausea and vomiting, and low blood counts. As 
chemotherapy affect the blood forming cells of the bone marrow, it leads to low blood cell 
counts and subsequently can lead to increased chance of infections, easy bruising or 
bleeding and fatigue. 
Along with these, some side effects are specific to certain medicines, for example: 
 Hand-foot syndrome can occur during treatment with capecitabine or 5-FU 
(when given as an infusion). This starts out as redness in the hands and feet, 
which can then progress to pain and sensitivity in the palms and soles. 
 Neuropathy (painful nerve damage) is a common side effect of oxaliplatin. 
Symptoms include numbness, tingling, and even pain in the hands and feet. It can 
also cause patients to have intense sensitivity to hot and cold in the throat and 
esophagus, causing swallowing problems. 
 Diarrhoea is a common side effect with many of these drugs, but can be 
particularly worse with irinotecan.  
Most side effects are short-term and tend to disappear after treatment is finished. 
Some, such as hand and foot numbness, may persist for a long-time.  
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Regarding to CRCs, the most common side related to the chemotherapeutic 
agents used are resumed in the table below. 
 
Regimens 
XELOX 
(capecitabina + 
oxaliplatin) 
FOLFOX 
(5-FU/LV/oxaliplatin) 
FOLFIRI 
(5-FU/LV/irinotecan) 
 
 
 
Side effects 
 Nausea and 
vomiting 
 Diarrhoea 
 Hand-Foot 
syndrome 
 Neuropathy 
 Risk of infection 
 Diarrhoea 
 Mouth sores 
 Han-foot syndrome 
 Numbness or tingling 
 Plantar-palmar 
syndrome 
 Nausea and 
vomiting 
 Risk of infection 
 Mouth sores 
 Anemia 
Type 
Neoadjuvant 
treatment 
Adjuvant treatment Palliative treatment 
Table 5. Most common regimens associated side effects in the management of 
CRCs 
 
It is well recognized that chemotherapies induce imunosuppression, depleting 
selectively a regulatory immune cell population at some doses – potential 
immunomodulation of chemotherapies.79 The local or systemic immunosuppression can 
prevent the formation, recruitment or action of cognate immune effectors, thus 
precipitating therapeutic failure and sealing the patient’s inexorable fate.80  
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4. CRC Immunity 
The development and progression of CRC may be influenced by different factors, 
such as microsatellite instability (MS) or inflammatory mediators. Inflammation is 
considered a risk factor for tumour progression and metastasis formation. According to the 
immunoediting theory, the innate and adaptive immune system can protect against tumour 
development. Moreover, as stated before, the tumour stroma influence growth, survival 
and invasiveness of cancer cells contributing to the tumour microenvironment, together 
with immune cells. 
Innate immunity, which is responsible for early detection and elimination of 
malignant cells, may be inefficient in patients who develop malignancy81. Several innate 
immune cells are implicated in CRC development and progression, macrophages, lower 
numbers and high density of mast cells, neutrophils, NK cells and DCs.82 
Studies suggest that tumour-associated macrophages (TAMs) enhance the 
proliferation of CRC cells.  This pro-tumorigenic activity is exert by the macrophages 
through mainly: (1) the release of IL-1β, which, subsequently, inhibit the tumour necrosis 
factor related apoptosis inducing ligand (TRAIL); and (2) the release of cytokines, growth 
factors and inflammatory mediators that may directly influence and stimulate the growth 
and migration of tumour cells; indeed, the macrophages’ release of IL6 and IL10 are 
associated with CRC progression and prognosis. A low number and high density of MCs, 
an elevated neutrophil/lymphocyte ratio, as well as the decreased number of NK cells and 
DCs are associated with worse prognosis, poorer survival time and higher rate of 
recurrence in CRC. 82 
 
It has been proposed that once CRC become clinically detectable, the adaptive 
immune response plays a role in preventing tumour recurrence and metastasis. The 
adaptive immune system seems to have a double-faced role, being the balance between 
immune-surveillance (CD8+ and CD4+ T cells) and tumour-promoting inflammation 
(diverse types of T lymphocytes) to change over time, and eventually dictating disease 
progression. 
CD8+ T lymphocytes constitute one of the leading effector of antitumor immunity 
by the release of lytic components via cell-cell interaction, the perforin. This cytolitic 
protein, is found in the granules of CD8+ and NK cells determines cell death by disruption 
of the cell membrane and the secreted enzymatic proteases leads to activation of the 
apoptotic pathway. The CD4+ lymphocytes are distinguished in Th1 lymphocytes, that 
secrete IFNγ, TNF and IL-2, and in Th2 Lymphocytes that secrete IL-10, IL-4 and IL-5. 
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The CD4+ lymphocytes have a regulatory action on CD8+ cells: IL-2 is essential for CD8+ 
T cells proliferation and TH2 cells limit CD8+ T cells proliferation. 
The role of B lymphocytes in cancer immunology remains complex and somewhat 
controversial. However they seem to play a complementary role in the antitumoral 
immunity: additionally to the antibody production, B lymphocytes mediate several other 
functions fundamental for immune homeastasis, namely the antigen-presenting role in the 
initiation of T-cell immune responses. Depending on their state of activation, B 
lymphocytes (in resting state) can suppress T-Cell mediated antitumour immunity by 
acting on CD4+ and CD8+ T cells and, when activated, can enhance the ability to 
generate tumour-infiltrating lymphocytes in vitro involving anti-CD3 and Il-2. 82 
In despite of undefined exact mechanisms in the regulation of tumour immunology 
is the role of regulatory T cells (Treg cells), a T-cell population that functionally 
suppresses an immune response by influencing the activity of another cell type. It was 
showed that increased levels of Treg cells are associated with a favourable prognosis in 
CRC and their role appears to depend on tumour pathogenesis. 83 
 
Human epithelial tumour cells of colorectal origin frequently produce the soluble 
carcinoembryonic antigen (sCEA) molecule, the soluble form of a tumour-associated 
antigen. sCEA has been evaluated as a phenotypic marker in relation to the presence of 
various cancer diseases. Identified as a member of the Ig superfamily, it has been shown 
to act as a homotypic and heterotypic cell-adhesion molecule. This production is directly 
related to the degree of differentiation, and it has been studied for its use as a prognostic 
marker for tumour progression and patient survival. It is known that sCEA can interfere in 
NK cell/ tumour-cell interaction and suppresses T- and B-cell responses. 84 In fact, the 
authors found that the increase in sCEA levels in patients with colon cancer is correlated 
with the rise in sIL-2R, IL-4 and IFN-γ serum levels, suggesting suppressive immune 
conditions, as IL-4 (a Th2 cytokine) suppresses IFNγ, inhibiting Th1 and NK cells. 
Berghella et al, also highlights the fact that the impaired NK cells functions can be re-
established using anti-CEA antibody in an in vitro model, suggesting that a correction of 
the host’s immune response could represent a new means of treatment for CRC. 84 
 
Resuming, despite the host immune system can initiate an immune response 
against CRC, tumour cells may utilize different ways to escape these defence 
mechanisms, such as the loss or downregulation of HLA class I antigens, the lack of 
co-stimulation defective death receptor signalling, apoptosis of activated T cells, 
immunosuppressive cytokines and activation of suppressor T cells.  
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The immune system may promote, in cases of chronic inflammation, progression 
of CRC, but also can induce tumour regression through the innate immune system with 
tumour specific activation of CTLs and effector CD4+ T cells. The high incidence and 
death rate of CRC suggest that the immune response is ineffective in many cases. 
 
4.1 Role of NK cells in CRC prognosis 
Prognosis of CRC patients is dependent on the local immunological tumour 
microenvironment. In addition to tumour stage, infiltration of NK cells in the tumour margin 
is independent prognostic factors in CRC patients. The infiltration of these cells into 
tumour is inversely correlated with the presence of a BM-like structure around the tumour 
cell nests and the presence of certain HLA-I loci. 85 
The results obtained from a study that analysed the number and activity of NK 
cells in the peripheral blood in patients with colon cancer, lead to the suggestion that 
reduced NK cell activity is associated with metastatic tumour growth in patients with colon 
carcinoma; and, if the decreased NK cell activity precedes the development of metastasis, 
it could constitute a possible a marker to identify a high risk of rapid tumour progression 
following curative colorectal surgery. 86 
 
Halama et al 87 found that NK cells are scarce in CRC tissue despite high levels of 
chemokines and cytokines, and the NK cell migration into CRC tissue is impaired early 
during tumour development by mechanisms that do not affect T-cell infiltration. In fact, 
they found that the early impairment of NK cells is decisive for CRC; the same is not true 
for other immune cells, especially for T cells which don’t have a so uniform presence 
during the different stages of CRC. Furthermore, they indicate a pivotal role for an escape 
from NK cells for CRC tumourigenesis and propose that quantification of NK cells within 
CRC tissue can be used as an important parameter for the detection of response therapy. 
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Traditional Chinese Medicine - Overview 
Traditional Chinese Medicine (TCM) is a broad range of medicine practices 
sharing common concepts which have been developed in China and are based on a 
tradition of more 5000 years, including various forms of herbal medicine, acupuncture, 
massage (Tui na) exercise (qigong) and dietary therapy.  
In the 1950s, these principles were modernized in order to integrate many 
anatomical and pathological notions with modern scientific medicine. Leibniz developed 
the binary numbering system out the I Ging (“The Book of Changes”, the oldest book of 
mankind) which enables to describe circular processes, the monad, bigram and trigram. 
The yin and yang signs as presented on this book may be considered as a mathematical 
expression of numbers (monad). Many of Chinese scientific principles, since Classical 
China teachings and before the Yellow Emperor’s Classic of Internal Medicine, 
emphasized the regulatory fluctuations through circulatory functions in a simplistic manner 
that is similar to a sinus wave and is part of the so-called monad (Leibniz) or Taiji sign.88 
Chinese Medicine may be defined as “a system of sensations and clinical signs 
and findings designed to define the regulatory state of the body” 89 For many thousand 
years is rooted on the approach that human being as whole and in interaction with its 
environment, thus embedded in the rhythm of the Universe.90 Chinese doctors look for the 
all active expressions of life which are seen as expression of a balance of energies that 
flow in a cyclic sequence along clearly defined conduits. Another major characteristic of 
Chinese medicine models is the concepts of functional systems, which are establish 
through a systematic arrangement of its observations, representing the symptoms of 
disorder, different manifestations of vital forces and various phenomena of life. The 
organization of the findings according to a system of correspondence allows identifying 
these functional systems (Zang Fu). 88 
The most fundamental element in Chinese medicine is the diagnosis89, and 
encompasses four major basis steps: a) eight diagnostic principles; b) recognition of the 
pathogenic factor; c) identification of orbs 1affected and d) constitution. According with 
Porkert88, Chinese medicine is primarily concerned with the function, movement and vital 
manifestations that characterize every pathological abnormality. “Agents” are defined as 
factors that elicit a functional deviation and these can be exogenous (climatic or social), 
endogenous (emotional or constitutional factors favouring a deviation from the normal 
function), and neutral agents. A pathological response (“heteropathy”) is a deviation or 
impairment from de straight or correct direction of function (“orthopathy”) and is 
determined by agents of disease. According to the ancient Chinese medicine the 
                                                 
1 Orbs refer to a group of diagnostically significant signs and findings that are grouped and named after organs or the 
region where some of the symptoms take place. 
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predisposition of each individual reacts and copes with diverse events in life is associated 
with the five elements (wood, fire, earth, metal and water), and that is reflected in the 
physical appearance as in emotional state/ behaviour. 
The “Heidelberg model” of TCM is a new scientific theory of Chinese Medicine that 
decodes the major postulations of Chinese medicine to western medical concepts and 
reveals the role of unbalanced states as major determinants of illness.91 
 
 
1. Heidelberg Model of Chinese Medicine: TCM as System Biology 
According to Greten,91 the integration of Chinese Medicine in Western Healthcare 
systems requires three preconditions: 1) Chinese Medicine should be rationally 
accessible; 2) Scientific evidence of the underlying mechanisms, clinical efficacy and 
general safety has to be raised and, 3) Quality control measures have to be put up on the 
basis of the developing knowledge of this medical system. 
The Heidelberg Model of TCM developed by Prof. Johannes Greten was 
supported by the pioneering works of the medical-sinologist Prof. Manfred Porket (1974), 
thus adopting a Latin terminology, and also supported by the Leibniz’ analysis of the I 
Ging (“The Book of Changes”). 
In the Heidelberg Model,91 which is a scientific model to allow a rational access to 
Chinese medicine and stresses the value of the internal logic of the Chinese Medicine, the 
central postulates of Chinese Medicine are recompiled and explained as a logical model 
of system biology based on a mathematical language.91 Leibniz developed the binary 
numbering system out the I Ging, which enables to describe circular processes, the 
monad, bigram and trigram. The yin and yang signs as presented on this book may be 
considered as a mathematical expression of numbers (monad). In classical Chinese 
natural sciences and philosophy binary numbers were used to describe circular 
movement, the quarter sections of a circular movement. An example of such a movement 
is the circular process of the seasons - spring, summer, autumn and winter. The Trigrams, 
representing 1/8th of the process allows to distinguish half-seasons or half-daytimes or 
shorter sections of the human behaviour which rhythmically occur during the day. The 
Taiji sign means that Yin and yang form a binary language of numbers that are able to 
describe circular functions such as regulation.  
The biological network of regulation in humans is polygenic and therefore not 
linear. In TCM four main descriptive models (guiding criteria - Bagang) have evolved to 
organize the complex relationships of body regulation, at four different physiological 
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levels: the neurovegetative level, humorovegetative level, the neuroimmunologic level, 
and the cellular level (figure 9). Current understanding of these criteria is that they consist 
of an extension of the vegetative regulatory curve on processes such as microcirculation 
(“heat/cold”), defence mechanisms (theory of six stages of the Shan Han Lun) and the 
relation of the amount of the cell population and the respective regulatory processes (the 
yin, “substance”).92 
 
 
Figure 10. The parallelism between TCM concepts of disease and physiological 
process at four levels of regulation, according to Heidelberg Model of TCM. 
 
 
The guiding-criteria, as directional standard conventions of physiology, permit the 
interpretation of the actual symptoms that are a manifestation of the overall body 
regulation. 
The first GC is repletion/depletion (“excess/emptiness”), and refers to clinical signs 
that have a primary neurovegetative origin. Repletion is analogous to relative over-
excitation of neurovegetative activating mechanisms, while depletion is a lack of 
respective activation or excess of de-activation.  
The second GC is “calor/algor” (heat/cold) and evaluates clinical signs 
predominantly originated from the humorovegetative system in western medicine terms. 
These signs include: (1) the effect of microcirculation within the disease on a systemic and 
regional level (local interdependent mechanisms of the plasma, blood cells, endothelium, 
and functional tissue); (2) the activation of body fluids, evoking vegetative and systemic 
responses in the context of fluid distribution, fluid supply and circulation. Thus, “calor” 
includes signs of over-activation of xue and “algor” signs of a lack of functional 
microcirculation. 
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The third GC is “extima/intima” (“exterior/interior”) and evaluates signs that 
apparently originate from the effects of a pathogenic factor (agent) invading the body from 
the exterior (The model of the six stages - Shang Han Lun; “algor laedens theory”). 
According to Prof. Porkert, the process of the agent “algor damaging the body” or “algor 
laedens theory” (ALT), have a parallel on clinical signs induced by neuroimmunological 
mechanisms, on western perspective. According to this theory, when “algor” affects the 
body system, it causes a regional  lack of microcirculation through defence reflexes to 
cold, through viruses (adhesion molecules, complement system, coagulation) in face of 
which and a counter-reaction (“reactive calor”) take place, resulting on a general increase 
in microcirculation, inflammation, fever and sepsis. 
The fourth GC is yin/yang and according to TCM, consists on the evaluation of 
signs that distinguish between primary deregulation (yang) and secondary deregulation 
due to structural deficiency (yin). In cases of deficient functional tissue, it prompts an 
up-regulation with increasing of tissue function that cannot be kept up and consequently 
resulting in functional deficiencies. In western terms, this can be explained by a deficient 
cell population that can be vegetatively overstimulated and cause vegetative clinical signs 
similar to repletion, followed by a phase of almost functional break-down with signs similar 
to depletion. As such, in yin-diseases, symptoms are due to deficiency of the functional 
tissue (“body substance”, yin). As the term “yin” refers also to xue2, body fluids3 and Jing4, 
the yin-diseases may also be due to lack of xue (lack of microcirculation within the tissue), 
lack of body fluids (lack of milieu-factors), lack of jing (impaired functions of the cell 
nucleus, or genetic deficits). Yang-diseases symptoms are due primarily to deregulation 
described by the first three guiding-criteria, while Yin-diseases by these last. 
Are described four kinds of mechanisms that may cause disease according to 
TCM: (1) excess of an agent; (2) transitional problems from one “evolutive phase5” to the 
next; (3) imbalance of antagonist phases; (4) yin deficiency. 89 
In summary, Chinese Medicine developed as a systematic rational on clinical signs 
which allow the definition of the regulatory status of the individual. As it has is foundations 
largely on reflexology and on a rational theory of vegetative (autonomic) nervous system 
activation patterns, Chinese Medicine can be considered a vegetative medicine, as 
postulated by the Heidelberg Model.89,91 
                                                 
2 Xue refers to a form of functional capacity bound to body fluids with functions such as warming, moisturizing, creating 
qi and nutrifying a tissue. 
3 Body fluids involve the concept of the hydratation and homeostasis of the tissue within the intersticial space. 
4 Jing refers to the structive potential and includes the functional repertoire of a cell via the DNA anda t the same time 
reproductive functions 
5
 Phase, in terms of Heidelberg model of TCM, refers to vegetative functional tendencies and it’s manifestations are 
called orbs. 
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Diagnosis according to the Heidelberg Model of TCM 
The Diagnosis is one of the most important elements in TCM.89 Based on 
Heidelberg Model; functional diagnosis is composed of four main steps (Figure 10): 
 The constitution: tendency of an individual to express predominantly an “orb 
pattern”. 
 The agent (pathogenic factor): is considered as a functional power or a “vector” 
that have the capacity to change the individual functional properties, producing 
clinical signs; 
 The “orb”, are group of diagnostically relevant signs that indicate the functional 
state of a body island, which correlates with the functional properties of a 
conduit 
 The guiding criteria, as previously described, is regarded as directional 
standard conventions of physiology, permit the interpretation of the actual 
symptoms that are a manifestation of the overall body regulation. 
 
 
Figure 11. The four components of functional diagnosis. 
 
 
2.1 The Algor Laedens (“harmful cold disease”) Theory – ALT 
According to Prof. Porkert, the ALT is the most common pathophysiological model 
that explains the process of “cold-invading” diseases in TCM, which have a parallel on 
clinical signs induced by neuroimmunological mechanisms on a western perspective 
(Figure 11). The ALT assumes that in case of “algor” affecting the body system, a regional  
lack of microcirculation may be caused by defence reflexes to cold, by viruses (adhesion 
molecules, complement system, coagulation) in face of which and a counter-reaction 
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(“reactive calor”) take place, consisting on a general  increase in microcirculation,  
inflammation, fever and sepsis. 
The model course of the ALT is suggested under the basic idea that the agent 
invades from the extima to the intima, thereby overcoming the defence levels and 
revolving the flow of qi and xue, and constitute a specific approach of interpretation of the 
guiding-criteria extima/intima, as stages I to III are extimal (yang) and stages IV to VI are 
intimal (yin). 
The ALT combines the language of the orbs (neurovegetatively originated signs) 
with the language of the system of calor/algor, a part of neuroimmunology, and reflects 
the functional activity of the defence mechanisms expressed by calor (yang) and algor 
(yin). 
The six stages of the ALT are syndromes composed of specific signs of two orbs, 
each. According to the model, the six stages form a complete circle of stages of an 
infectious disease. During the course of such cyclic process, an individual will overcome 
the infection and remain healthy thereafter. However, under certain circumstances, some 
signs of the six stages may remain and become chronic, such as in cases of fibromyalgia, 
rheumatic disorders, or chronic inflammation. 
 
The Three Yang/ Extimal Stages 
Yang stands for extima, for activity in general and within the meaning of the 
phases it stands for reactive calor. This is why among the first three stages, Stage II with 
the highest calor in the clinic is characterised very often by too much calor, being this 
reactive calor the responsible for the most of the symptoms. This over-riding, over-
extensive calor is in Chinese language called yangming, whose Latin transcription is 
splendor Yang (Stage II). In comparison to this splendor yang stage, the two other extimal 
stages can be divided into the yang that rises, Taiyang (Stage I) or in Latin the Yang 
major; and the lesser yang, Shaoyang, Yang minor (Stage III). 
 
The Three Yin/ Intimal Stages 
Within the yin, the intimal phases, the reactive calor is deficient resulting in internal 
algor; which could be defined as a yin state or a state of deficient functions that are under 
the target value of the production of warmth and heat. In these context, the target value 
states for balanced temperature behaviour of the body. Besides the hypofunctional state, 
the term yin also refers to the body substance, yin. The most pronounced lack of function 
seen on the Stage V, where the substance is used up, is called in Chinese Jue yin and in 
Latin Yin flectens meaning that the yin “goes away”, vanishes, but also bends. It 
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represents a turning point of the disease when it becomes life-threatening, dangerous and 
critical. 
The other two stages are, again, named in a comparative manner in relation to the 
acute Stage V. Thus, the Stage IV, where there is more substance blocked, more yin is 
called the bigger yin, Taiyin, yin major; and the stage where there is less substance left, 
the yin is smaller is named the smaller yin, Shaoyin, Yin minor – Satge VI. Another major 
aspect of these two Stages (IV and VI) is that the bigger yin has a downward direction, 
meaning that the hypofunctional state of internal algor is becoming more pronounced, 
“more yin” or yin major; in Stage VI the hypofunctional yin state have a upward direction 
comparable to the phase of water (regeneration) in the model of phases, having the 
capacity to regenerate to normal, is called lesser yin or yin minor. 
 
 
Figure 12. Schematic model of Algor Laedens Theory. 
 
 
Complementary, to the theory of the six levels another TCM theory prevails and 
states for the existence of six layers of functional powers within the body, six major 
defence mechanisms, which the agents have to overcome when invading the body – the 
six stages of defence (Figure 12). The extimal stages of defence encompass the 
defensive qi6 as first layer, followed by the qi of the conduits 7and, finally, the xue of the 
                                                 
6 Qi refers to vegetative capacity to function of a tissue or organ which may cause the sensation of pressure, tearing or 
flow. 
7 Conduits refer to a connection of a group of points with effect on the clinical signs of na orb, believed to serve as a 
conduit for the flow of qi and xue. 
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conduits; and the intimal stages includes the qi of the body island, followed by the xue of 
the body island and finally the yin.  
 
The energy layers comprise six technically different forms of energy: 
I. Defensive qi, also referred as wei qi, resides within the extima, outside the 
conduits and builds up the first barrier against external attacks. 
II. Conduit qi is the qi within the conduits. When this second layer of defence 
is affected by an agent causes a block in the flow of qi resulting primarily in 
pain and secondarily in functional disorders of the respective orb. 
III. Conduit xue, which is driven by the conduit qi and warms the conduits, 
“nourishes” and “moisturizes” the tissues. The warming effect on the tissue is 
needed e.g. to drive out the agent algor. 
IV. Body island qi is the qi within the intima, a general name for the whole 
body’s interior, where the functions of the orbs are generated in their 
respective parts of the body. 
V. Body island xue, is a substancial (yin) part of the body islands with 
warming, thus functionally activating and enhancing properties. 
VI. Yin, which is the functional tissue the respective subpopulation of the cells, 
the substrate out of which functions (yang) develop. 
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Figure 13. The six layers of energy. 
 
 
 
 
 
Therefore, it’s possible to distinguish six strategic scenarios (Table VI) in which the 
agent attempt to overcome each functional layer producing symptoms related to the 
invading agent (feeling of coldness) and symptoms that arise from the interaction of the 
agent with the layer of defence, which are specific key symptoms, thus enhancing 
diagnosis of the six layer model. 
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ALT STAGES ENERGY LAYERS MECHANISMS KEY SYMPTOMS 
I 
Yang major 
Defensive qi Regional lack of 
microcirculation 
Cold shivering, pale 
skin or goose bumps 
II 
Splendor 
Yang 
Conduit Qi Regional block of flow of 
qi or xue 
Algor-related pain 
(stabbing pain) and 
reactive calor (fever) 
III 
Yang minor 
Conduit xue Reverse flow of xue into 
the interior 
Hot/ cold sensations 
IV 
Yin major 
Body island qi Lack of microcirculation Mucus, swellings 
V 
Yin flectens 
Body island xue Lack of xue 
(blood, body fluids) 
Cold limbs, extreme 
fatigue 
VI 
Yin minor 
Yin Lack of yin (structural 
deficiencies) 
 
Bony appearance, 
stiffness of joints, 
prolonged 
regeneration or 
convalescence 
Table 6. The six stages of Algor-laedens Theory; Energy layers, mechanisms of 
action and key symptoms. 
 
Algor-induced signs and orb-signs evoked – ALT description 
When the agent algor invades the skin, it affects the defensive qi and may induce 
a localised de-activation of xue or in western terms a regional lack of microcirculation. As 
the body is unable to warmth that specific region, it produces generalised calor, reactive 
calor, to warmth the conduits and extima in order to expel the invading agent.  
Algor is a yin agent that diminishes the defensive qi as well as all other functional 
powers of the respective tissue, and in western concepts causes lack of microcirculation 
or de-activation of xue. Thus, algor may affect primarily the conduits that contain more xue 
than qi, the vesical and tenuintestinal conduits – ALT Stage I. If this attempt to expel algor 
fails, it may proceed the invasion and leading to a regional block of flow of qi and xue, 
thus causing pain. The flow of qi is blocked more easily than the xue, as “qi moves the 
xue”, so the phases and orbs more prone to this affection are the ones more dependent 
on qi, the Stomachal (S) and Crass Intestinal (CI) conduits – ALT Stage II. When the 
agent algor overcomes the flow of xue within the conduits, it may lead to a reverse flow of 
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xue into the interior, and if there is a relative lack of reactive heat, the algor may further 
invade causing sensations of cold in the interior. Frequently, xue from the inside will be 
mobilized against the agent causing sensation of internal heat again or, if the algor is 
driven out, even temporary heat of the exterior (skin). It may be said that the agent algor 
and the flow of xue within the conduit play “Tom and Jerry”, driving each other in and out 
repeatedly -- ALT Stage III. As this stage occurs still on the extima and the mobilization of 
internal heat is a feature of the phase wood, it affects the felleal (F) conduit and as this 
scenario causes symptoms and signs of “imbalanced distribution” of energies it also 
affects the tricaloric (TK) conduit. 
On the Stage IV, the calor is overwhelmed and the algor invade the interior as the 
interior is then a lack of microcirculation: the guiding-criteria algor is present. When the 
algor affects the qi of the body islands, the orbs affect are those more sensitive to 
diminished activity of qi, the lineal (L) and pulmonary orbs.  
When algor affects the xue within the interior, orb functions depending on xue are 
more easily affected, the hepatic and pericardial orbs – Stage V. When algor affect the 
body island xue, it represents the lowest point of energy in which reactivity has totally 
vanished, and is called the “flat-down” phase, a breakdown of orthopathy. Stage V is 
decisive for the survival of the individual. If, apart of yin, xue is sufficient then is possible to 
warm up slowly towards stage VI. 
The yin is the structural condition for the development of yang. Accordingly, also 
yin (functional tissue) is a technical form of energy. When this energy is affected by algor, 
signs of a lack of yin and a persistence of algor are seen. As yang arises from the yin (in 
the language of the 4th guiding-criteria), an analogue process in the technical terms of the 
1st guiding criteria is the development of yang qi upwards which is in a rapport with the 
cardiac qi. This connection is also expressed by the term of a cardio-renal axis, the yin 
pole being the renal orb and the yang pole the cardiac orb (Figure 13). 
 
Stage-hopping 
The six layers of defence consist of functional powers. They are gradually 
overwhelmed by the agent. If one of these functional powers is weak, overwhelming is a 
quick process. So in the case that the defensive qi is lacking, the result may be that the 
disease directly begins in Stage II. If the qi of the conduits is low, the disease will start 
directly with hot-cold sensations (Stage III). Lack of xue in the conduits results in cold 
extima, thus algor is able to invade the interior and symptoms of bronchitis are recurring 
(Stage IV). If the body island is deficient on qi, so xue is affected more easily, as in cases 
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of chronic burnout or hepatitis in mononucleosis (Stage V). If xue is lacking in the interior, 
stage VI is very probable. It’s frequently seen in old patients, especially in elderly women 
(Figure 13). 
 
Outside-Inside hopping 
Consists of an alternative pathway to agent’ invasion. This pathway is based on 
the fact, that all conduits are coupled with another conduit within the same phase 
(extimal-intimal connections). Thus, the agent may pass from an extimal conduit to an 
internal conduit. So, stage I can transform directly into Stage VI, Stage II can transform 
into Stage IV and Stage III into Stage V (Figure 13). 
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Figure 14. ALT related orbs and cross-linked orbs. 
Energetic factors determine the course. Variations in the course: outside-inside and inside-
outside hopping. Gretten 2010. 
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2.2 Cancer and Immunity according to TCM 
According to TCM, cancer occurs is due to an impairment of the smooth flow of Qi 
and/or an imbalance between Yin and Yang, manifests as a group of syndromes that are 
generally characterized through a disharmony in the body-mind-environment network.93 
A study performed 94 to determine the clinical diagnosis distribution in six common 
cancers and the expectation to uncover a theoretical basis for TCM diagnosis as a clinical 
cancer treatment, revealed that in colon cancer there are six main syndromes, such as 
pituita stagnation, Qi and xue deficiency, R and L deficiency, R and H yin deficiency, 
stagnation of blood and toxins and cold-dampness that affects the L. And among them the 
most prevalent described by the authors is pituita 8stagnation (Shi-Re-Yin-Jie syndrome; 
Figure 14). Pituita stagnation is caused by a malfunction of the lineal and stomach due to 
the retention of dampness and heat in the body and is characterized by epigastric or 
abdominal oppression, lack of appetite, heavy body weight, and thirst with little or no 
desire to drink, abdominal pain, loose stools, nausea, vomiting, fever, headache, red 
tongue body with a yellow sticky coat and/or slippery rapid pulse. This syndrome has been 
associated with many diseases, especially those involving the gastrointestinal tract as well 
as a broad range of inflammatory conditions (eczema, psoriases, cystitis, urethritis, 
gastroenteritis, vaginitis, cervicitis, meningitis, conjunctivitis, rheumatoid arthritis and 
allergic reactions). In fact, is has been reported that the symptoms characteristic of pituita 
stagnation are common among gastrointestinal cancer patients, including cancers of 
duodenum, colon, liver, pancreas and gallbladder.  
 
 
Figure 15. Most common cancer syndromes, according to TCM. 
Extracted and modified from Chen et al. 94 
 
 
Also, it has been described an correlation between this syndrome and alterations 
on the expression of inflammatory cytokines such as TNF- and IL13, as well as others 
cytokines involved in cancer-associated myofibroblast proliferative activities and in 
                                                 
8
 Pituita, according to Heidelberg model, refers to accumulation of humor and reactive calor during time. In 
western terms refers to chronic inflammation signs that may originate from pre-oedema and oedema. 
Pituita stagnation 
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tumour-associated macrophage infiltration. Thus, suggesting that there is an association 
between pituita stagnation and changes in tumour microenvironment.94 
The terms related to immune functions in TCM are zheng qi, yuan qi, yang qi, wei 
qi, qi of zang fu9, including lung (pulmonal) qi, spleen (lineal) qi and kidney (renal) qi, 
along with the related materials and function such as jing, qi and shen10. 95 
 
"If zheng qi remains strong, xie qi cannot invade the body, zheng qi must be weak when 
invasion of xie qi takes place." 
Zheng qi consists of yuan qi (primary or congenital qi), zong qi (pectoral qi), ying qi 
(nutrient qi), wei qi (defensive qi), and qi of all the zang fu organs. Zheng qi consists in the 
physiological functions of zang fu organs, meridian channels and tissues. It also 
represents the adaptability and accommodation of the body to the environment and the 
resistance of the body to diseases. Since zheng qi represents such a broad category, it is 
clear that zheng qi is involved in the immune system. From a western point a view, zheng 
qi appears to represent the nerve-endocrine-immune network.  
 
Wei qi (defensive qi), also called wei yang, is derived from the fierce qi of food 
essence. It is part of the yang qi that circulates outside the blood vessels and protects the 
surface of the body, such as skin and muscle, from exogenous pathogenic factors, 
controls the opening and closing of pores, moistens the skin and hair, regulates body 
temperature and warms up the zang fu organs. From a western point of view, some 
functions of wei qi correspond to those of the autonomic nervous system and the central 
nervous system. These facts indicate that wei qi is related to the defense function, but it is 
very limited, being far from enough to explain the function of the immune system. 95 
 
Qi of zang fu. In the study of zang fu, researchers try to find the relationship 
between the micro-index in immunology and symptoms in traditional Chinese medicine. 
For example, the heart governs blood and the vessels. It has been reported an 
association between heart qi deficiency and deficient cell-mediated immunity in patients 
with coronary disease; but not with the humoral immunity. 95 
                                                 
9
 Zang Fu means organs and visceras. 
10 Shen, according to Heidelberg model of TCM, refers to functional capacity to put order into mental associativity and 
emotions, thus creating “mental presence”. 
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The lung dominates qi, controls respiration and connects with skin and hair and 
also regulates water passages. Deficient lung qi appears to be associated with low 
transformation rate of lymphocytes, IgG and IgM. 95 
The spleen controls digestion, assimilation and distribution of nutrients and water 
throughout the body. Hence, the spleen and stomach are viewed as the foundation of the 
latter heaven-acquired constitution. 95 
"If the Spleen qi is strong during all four seasons, the body will not be attacked by evil qi.”; 
"All diseases start with Spleen and Stomach deficiency." 
The spleen deficiency was found to be mainly a result of the dysfunction of the 
digestive system and it involves the nerve-endocrine-immune network. In which, the ability 
to produce antibodies is low, humoral immunity is deficient, Th-cell (helper T-lymphocytes) 
count is low, suppressor T-cells is high and cell-mediated immunity is deficient. 95 
The liver stores blood, maintains the free flow of qi and stores the soul. It has been 
shown that stagnation of liver qi causes reduction of lymphocytes E-rosette, namely the 
ability of releasing H2O2 from monocytes and mixed lymphocyte reaction; thus liver 
stagnation is implied in deficiency of the immune function. 95 
The kidney stores vital essence, dominates water metabolism, development and 
reproduction. It is in charge of bone and manufacturing bone marrow. Kidney deficiency 
was shown to be associated with low levels of T helper lymphocytes, serum hemolysin 
and plaque-forming cell assays and high levels of suppressor T-lymphocytes. These facts 
suggest that the ability to produce antibodies is low in the kidney-deficient patients. Kidney 
yang deficiency is associated with low levels of serum IgG while in kidney yin deficiency, 
serum IgM is elevated, urine IgG and IgA are elevated. 95 
In modern medicine, the pituitary-adrenal cortex-lymphocyte corticoid receptor is 
the important part of nerve-endocrine-immune network. The lymphocyte corticoid receptor 
is the peripheral connector of the nerve-endocrine system with the immune system. The 
kidney, in traditional Chinese medical terms, has a very close relationship with the 
nerve-endocrine-immune network.  
 
Resuming, each organ in TCM corresponds to several organs and various 
physiological systems in Western medicine, especially the nervous, endocrine and 
immune systems. In all of the organ deficiency-type symptoms, there is a certain reduction 
of the immune function. On the other hand, the nervous-endocrine-immune network runs 
through every organ in the body. The immune system has its special structure and 
function. It is not the same as zhang fu organs. The structural difference is clearly 
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demonstrated by the anatomy which should be distinguished from the unique function of 
the immune system, for example spleen deficiency in the common situation is different 
from the spleen deficiency in AIDS.  
In recognizing immune-related diseases, it is necessary to point out that the major 
pathological changes are in the immune system. Using zang fu qi to represent the 
immune function cannot reveal the special nature of the immune system and its important 
role in the development of diseases. 95 
 
2.3 Cancer and Immunity - Heidelberg Model of TCM  
As discussed previously, defensive qi constitute the foremost defence line of an 
individual. This kind of active energy that resides within the extima, outside the conduits 
and gives warmth to the flesh, its normal tonus to the skin, regulating the opening and 
closing of the pores and all other functions by which this tegument responds to outward 
stimuli. “Qi” designates the active aspect of all energies constituting the vital functions of 
an individual. Therefore, an affection of the Qi implies that a disturbance has penetrated 
deeper and spread further than if it affects only the defensive energy. Since the defensive 
energy is essentially deployed in the skin, the pulmonal orb (P orb) has an eminent role 
within the defence system of each individual. The specific function of P orb is giving the 
rhythmic cue for the deployment of energy at all levels of personality.88 
 
Qi construtivum is the term designating the aspect of that structive energy (xue) 
which flows within the conduits, and totally represents the circulation of energy between 
all orbs, thus contributing to and maintaining the material development and sustenance of 
the body. When this kind of energy is affected gives rise to symptoms such as impairment 
distribution of blood, restlessness and apprehension, etc. Qi Constructivum and xue 
constitute different technical aspects of ultimately the same structural energy. In Chinese 
Medicine xue refers not only to blood, but also to the basic form and concept of all liquids, 
fluids and secretions. Thus, affections of the xue contribute to a serious and even critical 
state of illness.88 The hepatic orb (H orb) on one hand is responsible for the mobility of the 
individual, for the production and employment of locomotive force, for the active projection 
of the personality in general; and on the other hand, is responsible for the storage and 
dosage of individually specific structive energy (xue). The hepatic orb is mostly affected by 
repletion rather than depletion. In cases of repletion of the H orb there are two possible 
types of agents: (1) emotions that impair the normal outflow of energy from the H orb, 
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producing congestions eventually leading to ardor11. As a consequence, the storage and 
control of active energies may be impaired producing symptoms of ventus 12internus; (2) 
algor externus retained in the conduits of H orb, producing congestive symptoms, 
encroachments or contravections of the qi hepaticum, general lack of force and drive, 
pains, congelations, and indirectly hematomas and congestions, spastic tensions, 
tympanites, constipation and finally concretions (tumours).88 
 
In summary, according to Heidelberg Model of TCM, cancer may result from an 
imbalance on the Metal-Wood axis. These represents an imbalance of Qi defensivum 
and Qi construtivum, where Qi defensivum can be understood as a vegetative defence 
mechanism originated in the respective tissue itself and promoted by the continuous 
action of inspiration and expiration, as well as the vegetative rhythm induced by that; and 
Qi construtivum is derived from xue, which corresponds to the western term of 
microcirculation (MC). This is analogous to the concept that growth factors, hormones and 
other factors, which will normally contribute to tissue repair, would reside in the respective 
tissue as a result of impaired flow of MC, possibly induced, as among other factors, by a 
lack of capillary outflow. From a western perspective, this is to be regarded as a 
vegetative theory of carcinogenesis. This implies, also, the inclusion of emotional 
changes and psychosocial causes of cancer by Chinese medicine.  
 
Chemotherapy – TCM Heidelberg Model Perspective 
Chemotherapeutic agents are considered as a form of algor, toxic algor, which 
leads to the occurrence of symptoms of coldness, tiredness and stiff limbs, and, therefore 
can be interpreted by the ALT. 
Primarily, there are two aspects that need to be considered: the first is that an 
hypofunctional state (yang deficiency) leads to ice coldness, weakness and extreme 
sensitivity to external cold, and the second is that chemotherapy, considered as toxic 
algor, induces cold directly and may affect all the six levels of Qi in the ALT and the 
symptoms presented by the patient differs according to the stage of invasion. 
On Stage I, the wei qi is deficient, the most common algor-related signs are 
shivering and painful limbs. On Stage II, patient reveals severe and tearing pain in 
different regions of the body, loss of appetite, nausea and extreme sensitivity to smell. As 
                                                 
11
 Ardor resembles to the feeling of a piece of glowing charcoal touching the skin or other organs, producing intense pain 
with reddishness of pulsating nature, just as seen in inflammation conditions. 
12
 Ventus refers, in western terms, to a neurovegetative reaction “as if in a draught of air”, with two mechanisms: archaic 
turning movement (autochthonic muscules) and substance P-mast cell reflex. 
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on this stage, the algor affects the Stomach orb and patient develops a splendour yang 
syndrome with accumulation of pituita, which affects the face becoming swollen. Also 
affects the CI, appearing gradual diarrhoea and pain in the abdomen. On Stage III, 
appears on the beginning of the chemotherapy, where the xue of the conduits is affected, 
and giving rise to the alternating sensations of hot/cold. When toxic algor, affects the qi of 
P and L orbs leads to more vulnerability to airways infections and feelings of dullness 
(accumulation of humor13), respectively – Stage IV. In Stage V, the xue of H and PC body 
islands is affected, thus the muscles become inactive (weakness of arms and legs) and 
also may give rise to palpitations, loss of drive and weakness due to the presence of toxic 
algor in the pericardium or heart muscles. On Stage VI, the extreme yin deficiency 
(cachexia) is due to (1) tumour itself, but also enhanced by chemotherapy; (2) affection of 
structure and function – the R orb is affected occurring symptoms such as pain in the 
bones, stiffness in all joints, myalgic and weak muscles; (3) affections of the urinary tract 
(frequent urination); and (4) affection of the brain, more precisely short-memory loss. 
In summary, and according to the theory of phases, cancer reflects impairment 
on Metal-Wood axis, represented by the P orb and H orb. According to ALT, these orbs 
(P and H) correspond to stage IV and V, and are coupled to L and PC orbs, respectively. 
Regarding to chemotherapy effects, it may be considered that “toxic algor” is the agent 
that directly affects all ALT stages. In addition, one may extrapolate that cancer patients 
undergoing for chemotherapy are in a hypofunctional state, between stage IV (P and L 
orbs) and V (H and PC orbs), and most probably symptoms are sensitivity to cold, 
weakness of the limbs, tiredness, feelings of dullness and vulnerability to airways 
infections. However, as described before through the intimal-extimal connections of the 
conduits, Stage II and Stage III symptoms may be seen, such as nausea, loss of appetite 
and hot-cold sensations. 
 
3. Acupuncture - overview 
Acupuncture has been employed as a health care modality for over 3000 years. 
Over the last few decades research has been carried out seeking to explain how 
acupuncture works, and what it can and cannot treat. 
The 1997 National Institute of Health (NIH) Consensus of Acupuncture reports that 
“studies have demonstrated that acupuncture can cause multiple biological responses, 
mediated mainly by sensory neurons to many structures within the central nervous 
                                                 
13
 Humor refers to a group signs originated from pre-oedema and oedema, such as swollen limbs and tissues, feeling of 
heaviness, dyspnoea and generalised pain. 
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system. This can lead to activation of pathways affecting various physiological systems in 
the brain as well as in the periphery”. 
The NIH Consensus also suggests that acupuncture “may activate the 
hypothalamus and pituitary gland, resulting in a broad spectrum of systemic effects. 
Alteration in secretion of neurotransmitters and neurohormones and changes in the 
regulation of blood flow, both centrally and peripherally have been documented. There is 
also evidence of alterations in immune functions produced by acupuncture.” 
It has been proposed different theories on the mechanism of acupuncture.96,97,98 
a) Neurotransmitter Theory – acupuncture effects higher brain areas, 
stimulating the secretion of β-endorphins and encephalin in the brain and spinal cord, 
which influences the immune system and the antinociceptive system. 
b) Autonomic Nervous System Theory – acupuncture stimulates the release of 
norepinephrine, acetylcholine and several types of opioids, affecting changes in their 
turnover rate, normalizing the autonomic nervous system and reducing pain. 
c) Gate Control Theory – acupuncture activates nonnociceptive receptors that 
inhibit the transmission of nociceptive signals in the dorsal horn, “gating out” painful 
stimuli. 
d) Vascular-interstitial Theory – acupuncture manipulates the electrical system 
of the body by creating or enhancing closed circuit transport in tissues. This facilitates 
healing by allowing the transfer of material and electrical energy between normal and 
injured tissues. 
e) Blood Chemistry Theory – acupuncture affects the blood concentrations of 
triglycerides, cholesterol and phospholipids suggesting that acupuncture can both rise and 
diminish peripheral blood components, thereby regulating the body toward homeostasis. 
 
 
4. Acupuncture and Immunomodulation 
Mark Bovey in a review of the literature99 verified that there are many publications 
from around the world that demonstrate that acupuncture can affect different aspects of 
the immune system. However, an investigation into the specific area of chemotherapy-
induced neutropenia/ leukopenia is almost entirely dependent on Chinese research, most 
of it written in Chinese and published locally. Although, the best information comes from 
the review and meta-analysis of Lu et al, 100 which reported a significant effect of 
acupuncture in comparison to usual care but pointed out that there were major 
deficiencies in the quality and reliability of the reports on which this result was based. 
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Subsequently workers from the same US cancer institute have published data from their 
own small pilot trial,101 which largely confirms the Chinese results, suggesting that 
acupuncture treatment could protect against myelosuppressive chemotherapy. 
 Bovey conclude that there is enough indicative evidence of effect, together with 
enough information on how to deliver the acupuncture treatment, to consider a) trying to 
replicate the US results, either with the same type of cancer or another, b) a pilot study 
comparing acupuncture to normal medical care, rather than ‘sham’ acupuncture, and/or c) 
running a larger trial. 99 
Acupuncture seems to operate through multiple mechanisms in its effect on 
leukopenia, promoting the release of WBC from bone marrow cells into the peripheral 
blood; prolongs the life of WBC; increasing the activity of CSF; promoting the proliferation 
of haematopoietic stem cells; diminishing the damage to done to haematopoietic stem 
cells by chemotherapy; improving the microcirculation.99 In concordance to these studies, 
Lu et al100 reported also that acupuncture could increase serum CSF and promote the 
maturation of granulocytes. They also cited evidence of an effect on non-marrow factors, 
hence again suggesting multiple mechanisms. 
Humoral and, especially, cellular immune function have been reported as being 
boosted by acupuncture and moxibustion in cancer patients with significant increases in 
several T lymphocyte subsets. Immune system modulation has been noted also for 
various other conditions, such as asthma, 102 autoimmune and inflammatory diseases103. 
Takahashi et al,104 reviewed the ascribed immunomodulation of acupuncture and 
conclude that acupuncture treatment appears to be able to modulate immunosuppressed 
or immunoactivated conditions through various functions, including the activities of 
macrophages, neutrophils, NK cells and lymphocytes, immunoglobulin production and 
complement systems. In fact, it was previously reported two possible mechanisms 
involved: NK-related gene expression in the spleen 105 and the sympathetic nervous 
system106.  
A recent review 107 about the mechanisms of acupuncture in modulating various 
immune responses and the relationship between acupuncture mediated immune 
regulation and neurological involvement, indicates an immunomodulating role of 
acupuncture. The authors verified that acupuncture enhances the NK cells activity and its 
subsets 108; modulates the balance between Th1 and Th2 cells and acupuncture treatment 
may affect somewhat different neural-immune signalling pathway depending on the 
condition (e.g. normal vs. Th1-dominant vs. Th2-dominant conditions). 
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Figure 16. Hypothetic model of the mechanisms how acupuncture stimulates the 
immune system. Acupuncture stimulation of ST36 acupoint induces release of nitric oxide (NO). 
NO, a neurotransmiter, stimulates via the sensory nerves, spinal cord and medulla oblongata, 
gracile nucleus the lateral hypothalamic area (LHA), where it promotes secretion of opiod peptides 
such as β-endorphin. β-endorphin travels via blood circulation to the spleen and other body 
locations containing immune cells where it binds to opiod receptors expressed on the surface of NK 
cells and stimulates NK cells to amplify their expression of cytotoxic molecules and consequently 
tumoricidal activity, and production of IFN-γ. This cytokine induces the expression of NK cell 
receptors and cytokine receptors on NK cells and perhaps cytokine secretion by other immune 
cells, thereby orchestrating and further amplifying anticancer immune functions. Extracted from 
Johnston et al 2011
109 
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Moreover, Johnston et al,109 have combined heterogeneous research findings with 
cellular immunological and molecular biological theory producing the “acupuncture 
immunoenhancement hypothesis”: acupuncture stimulation increases the cytotoxicity of 
NK cells by promoting cross talk between the neurotransmitter network and immune 
system that is [1] orchestrated by nitric oxide, β-endorphin and cytokines and [2] anchored 
by opioid and NK cell receptors (Figure 15). 
Silvério-Lopes and Gonçalves-Mota110 review the literature about the role of 
acupuncture in modulation of immunity. The authors concluded that the principal 
immunomodulatory effects of acupuncture include: a) decrease of cellular apoptosis; b) 
increase cytotoxic activity; c) biochemical synergism between electro-acupuncture and 
neurotrophyn; d) mobilization of corticosterone, endorphine and ACTH; and e) 
pro-inflammatory and anti-inflammatory effects. Moreover they verified that in all studies 
about immune response, the NK cells were used as markers and there was an increase of 
these cells after acupuncture and electroacupuncture treatment. No study revealed a 
reduction of NK cells expression. 
 
 
In respect to studies on CRC, we found the reports of only two Chinese studies. 
One study focus in the effect of acupuncture on the activity of the peripheral blood T 
lymphocyte subsets and NK cells,111 showed that the value of T lymphocyte subsets such 
as CD3, CD4, and CD8 , as well as NK cells were obviously increased after treatment, 
and there were significant differences between them before and after treatment. The other 
study has focus in the effects of moxibustion on the improvement of gastrointestinal and 
immune function in patients with postoperation of CRC112 .The authors concluded 
warming needle moxibustion constitutes a good therapeutic effect and is able to regulate 
bidirectionally peripheral blood lymphocytes and neutrophil granulocyte and improve T 
lymphocyte subgroup and NK cells, promoting the recovery of immune function of these 
patients. 
 
 
5. The importance of moxibustion in the immune modulation 
Moxibustion is an important part of the science of TCM, being documented in the 
Han dynasty silk books. These books have been discovered in 1973 and there was no 
mention of acupuncture therapy leading to presume that the origin of moxibustion is 
previous to that of acupuncture. 
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Moxibustion is a part of acupuncture practice for 1000 years and entails burning 
the moxa herb Artemisia vulgaris to warm points in order to alleviate symptoms. 
According to TCM, moxa is warm in property and fragrant in flavour and have the 
functions of smoothing and facilitating circulation in the 12 meridians, regulating the qi and 
blood, expelling coldness and dampness. According to modern research, moxibustion can 
promote metabolism, improve immune system functions and regulate the physiological 
function of internal organs. 
Moxibustion can be administered by different ways: a) through a burning moxa 
stick directly over the skin at an acupoint – direct moxibustion; and b) indirect moxibustion, 
that consists in placing insulating materials such as sliced ginger or garlic between the 
body and a burning moxa cone. 
It has been postulated that the mechanism of moxibustion effect is associated with 
the pharmacological action of the materials used, the thermal action and the infrared 
radiation. However, to some researchers the thermal effect of moxibustion is the key to its 
therapeutic effect, because it stimulates three different types of sensory receptors - cold 
receptors, warmth receptors and pain receptors – that enable the perception of gradations 
of thermal sensation. So, these authors attribute to moxibustion the capacity to activate 
and modify the nervous system by stimulating receptors under the skin. The exact effect 
of the afferent information on thermal sensitive neurons and the involvement of the 
sympathetic nerve system remain unknown but are the important links of moxibustion 
therapy.113 
 
Freire et al114 in order to assess the physical characteristics underlying the action 
of moxibustion in specific acupoints, verified that the therapeutic effect is also dependent 
on the temperature and the material used for moxibustion. 
As stated previously Zhang et al112 reported that warming needle moxibustion has 
a good therapeutic effect on gastrointestinal function and can regulate bidirectionally 
peripheral blood lymphocyte and neutrophile granulocyte and improve the T lymphocyte 
subgroup and NK cells so as to promote the recovery of immune function in patients with 
CRC after operation. 
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PART TWO – STUDY METHODOLOGY 
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1. OBJECTIVES 
 
The objectives of this study are: 
 evaluate the effect of AcuMoxa protocol, according to Heidelberg Model of TCM, 
on NK cells in CRC cancer patients undergoing for chemotherapy; 
 evaluate the effect of increased NK cells on the patients emotional state; 
 evaluate the effect of increased NK cells on the patients quality of life 
evaluate the increased NK cells on the patients. 
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2. Sampling and Recruitment Procedures 
 
Selection of patients 
This study was approved by the ethics comission of Centro Hospitalar S.João and 
Centrp Hospitalar Vila Nova de Gaia/ Espinho. Written informed consent was obtained 
from all patients before study enrollment. Patients were eligible for inclusion as follows: 
newly diagnosed or recurrent colorectal cancer, regardless of stage; receiving 
myelosuppressive chemotherapy; no regular use of acupuncture within 120 days prior to 
enrollment; ability to give informed consent; and 18 years of age. Exclusion criteria were 
the following: absolute neutrophil count (ANC) less than 500/μL; (b) platelet count less 
than 25,000/μL; (c) altered mental state; (d) clinically significant cardiac arrhythmias; and 
(e) other unstable medical condition.115 
 
Study design 
All patients enrolled were evaluated at baseline. Patients were randomized into one 
of two groups: active acupuncture (AcuMoxa) or non-acupuncture (control group). All of 
the study patients, were blinded to randomization assignments. 
Patients in the experimental group received 6 sessions of acupuncture, twice a 
week, beginning 1 week prior to cycle of chemotherapy and ending at the beginning of the 
following cycle  of chemotherapy (Fig. 17). At the conclusion of the intervention, patients 
in the study arm continued their remaining chemotherapy cycles without any acupuncture 
treatment. Patients in the control arm were offered the active acupuncture protocol 
immediately after they completed the four weeks of blood sampling as a courtesy.  
 
Acupuncture protocol 
All acupuncture treatments were performed at Centro Hospitalar S. João and Centro 
Hospitalar de Vila Nova de Gaia/Espinho. The acupuncture treatments were administered 
only by one acupuncturist (the researcher). A standardized acupuncture protocol was 
developed, which was based on Heidelberg Model of TCM. 
The experimental group (AcuMoxa).  Acupuncture points and their anatomical 
locations were as follows: lower extremity (LR3, ST36, SP9, VB39); upper extremity (LI4, 
PC5, Tk5, P7) and lower abdomen (Rs 6). Disposable acupuncture needles with a size of 
36G, 0,20x25mm (Tewa®). The depth of needling was at approximately 10mm. A de qi 
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sensation was required. The moxa treatament was used in the following points: IT6, TK5, 
S32. Each session was 45 minutes. 
The control group. The individuals collect the blood sample as the experimental 
group, during 4 weeks. And then it was administered acupuncture treatment to the 
individuals. 
 
Clinical and laboratory evaluation 
Complete blood counts were collected at baseline, and then once every 7 days at 4 
time points during the study period (Fig.17).  
Lymphocyte populations and NK cells (total counts and subsets counts) were 
analysed by flow cytometry (CD45-FITC/CD56-PE/CD19-ECD/CD3-PC; Beckman Coulter 
Portugal), at department of Immunology of Hospital Santo António, Porto. 
 
 
 
 
 
 
 
 
Figure___:  
 
 
 
 
Day 1 Day 8 Day 15 Day 22 Day 29 
1st chemo 1st recovery day = 2nd chemo 2nd recovery day = 3rd chemo 
Baseline 
CBC, NK  
T 1 
CBC, NK  
T 2 
CBC, NK 
T 3 
CBC, NK 
Chemo Cycle 1 Chemo Cycle 2 
Decrease 
WBC/ANC 
Figure 17: Study flow chart. Black solid dots: time points of outcome measurements. Open circle: ﬁrst 
chemotherapy day. Black diamonds: the primary endpoints of the study. Dashed lines: the expected 
changes, during chemotherapy, of white blood cells (WBC) and absolute neutrophil counts (ANC). 
Short, blue down arrows: acupuncture treatments. CBC, complete blood counts; NK, NK cells and 
subsets. 
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3. Statistical analysis 
This study was designed to provide preliminary data to inform the design and 
analysis of a subsequent large-scale, fully powered study to evaluate the effects of 
acupuncture on NK cells in patients with CRC.  
 Nonparametric Wilcoxon–Mann–Whitney tests were used to assess between-group 
comparisons as unadjusted analyses. Pearson analysis of correlation was used to 
examine variables correlations.  
The analysis was performed in accordance with the intention-to-treat principle. 
Missing data were handled based on available data approach. SPSS for Windows was 
used for statistical computation. All p value <0.05 was considered statistically signiﬁcant. 
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PART THREE – RESULTS AND DISCUSSION 
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1. RESULTS 
 
Baseline characteristics - Sample characterization 
 
At baseline, the patients and the controls shared similar demographic and clinical 
characteristics (Table 7).  
The majority of patients (88,9%) have a colon cancer, with stage II (16.7%) and 
Stage III (55.6%); 66,7% of the patients are submitted to the Folfox chemotherapy 
regimen and 16.7% of the patients undergoes with the Xelox chemotherapy regimen. 
 
 
 
Experimental Group 
 
Characteristics  
 
Control Group 
 
62.2 
38-74 
Age 
Mean 
Range 
 
56.6 
43-74 
 
8 (88.9%) 
1 (11.1%) 
Cancer Type 
Colon 
rectum  
 
9 (100%) 
0 
 
1 (11.1%) 
7 (77.8) 
1 (11.1%) 
Tumor Staging 
II 
III 
IV 
 
2 (22.2%) 
3 (33.3%) 
4 (44.4%) 
 
6 (66.7%) 
1 (11.1%) 
1 (11.1%) 
1 (11.1%) 
Type of chemotherapy 
Folfox 
Xelox 
Folfiri 
Capecitabine  
 
6 (66.7%) 
2 (22.2%) 
0 
1 (11.1%) 
 
Table 7: Socio-demographic and clinical characteristics of patients. 
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Comparison of blood analyses at baseline showed no statically differences among 
groups (Table 8). 
Experimental Group 
(n=9) 
Baseline Blood analyses 
(Mean; s.d.; p value) 
Control Group 
(n=9) 
 
5.842; 0.897  
49.01; 11.74  
27.54; 9.00 
10.17; 2.66 
78.33; 6.99 
11.48; 5.53 
10.67; 4.77 
0.80; 0.89 
 
WBC (AbsV.); p=0.400 
ANC (%); p=0.479 
Total Lymphocyte (%); p=0.456 
B cells (%); p=0.369 
T cells (%); p=0.099 
NK cells (%); p= 0.07 
NK 
bright
 cells (%); P=0.06 
NK 
dim
 cells (%); p=0.408 
 
5.916; 1.288 
53.19; 12.68 
31.88; 14.45 
7.88; 6.9 
85.38; 9.84 
6.66; 5.00 
6.17; 4.58 
0.48; 0.69 
Table 8: Blood analyses at baseline. Comparison between groups. 
 
A total of 18 (100%) patients completed the questionnaires of QOL-CR29 and HADS 
at the beginning and at the end of the study. Comparison of QOL and Anxiety and 
depression scores did not reveal any statistical differences among groups (Table 9); 
however the experimental group reveals high scores of depression. 
Experimental Group 
(n=9) 
(Mean; s.d.) 
QOL-Cr 29 & HADS scores 
(Mean; s.d.)(p value) 
Control Group 
(n=9) 
(Mean; s.d.) 
14.78 
16.11 
7.67 
7.67 
6.22 
2.89 
8.33 
3 
0.78 
2.44 
4.56 
2.89 
Anxiety (p=0.722) 
Depression (p=0.432) 
Urological Symptoms (p=0.632) 
Gastrointestinal Symptoms (p=0.609) 
Defecation symptoms (p=0.78) 
Stoma-related symptoms (p=0.66) 
Chemo side effects (p=0.96) 
Male sexual function (p=0.239) 
Female sexual function (p=0.148 
Weight concerns (p=0.857) 
Body image (p=0.819) 
Future concerns (p=0.398) 
15.67 
14.33 
7.89 
8.44 
10.67 
--a 
6.67 
1.56 
1.78 
2.56 
4.78 
3.33 
Table 9. QOL-CR 29 and HADS Scores. Comparison between groups at baseline.  
a
. no patient in the control group with stoma. 
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Effect of acupuncture on WBC and ANC 
The effects of acupuncture treatment on WBC counts and ANC in study patients are 
shown in Table 10.  
 
Groups T0 T1 T2 T3 
Control 
WBC (AbsV. Mean; s.d.) 
ANC (% Mean; s.d.) 
(n=9) 
5.916; 1.288 
53.19; 12.68 
3147 
(n=9) 
5.087; 1.03 
51.04; 8.89 
2596 
(n=9) 
5.300; 1.264 
53.58; 14.57 
2839 
(n=8) 
4.863; 0.806 
52.22; 9.74 
2539 
Experimental 
WBC (AbsV. Mean; s.d.) 
ANC (% Mean; s.d.) 
(n=9) 
5.842; 0.897 
49.01; 11.74 
2863 
(n=9) 
6.368;1.922 
50.31; 11.23 
3204 
(n=9) 
7.563; 2.930 
56.77; 10.1 
4294 
(n=8) 
6.826; 1.971 
54.46; 15.28 
3717 
Table 10: WBC (absolute value(AbsV) means and standard deviation) and ANC (percentage 
means and standard deviation), in both groups at different time points. 
 
 
The difference in WBC counts between the two groups became statistically 
signiﬁcant after patients received 4 sessions of acupuncture (p=0.049) and remain higher 
at time point T3 (p=0.019). 
 
Differences in ANC values between AcuMoxa and control groups showed a pattern 
similar to that of WBC counts but were not statistically signiﬁcant. At the end of the study, 
average ANC values in the AcuMoxa group were greater than in the control group. 
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Graphic 1: WBC and ANC counts. 
 
Effect of acupuncture on lymphocyte populations 
The average of total lymphocyte populations were not statistically different among 
groups (Table 11 and Graphic 2), either on the lymphocyte population B. However, the 
percentage of total lymphocytes are higher in the experimental group and the B cells have 
a increasing tendency, being significantly higher in the experimental group. Among T 
cells, the control group exhibits statistically significant higher levels of T cells, since time 
point T1. 
 T0 T1 T2 T3 
Total Lymphocyte  
(% Mean; s.d.) 
Control  
Experimental 
(n=9) 
31.88; 14.45 
27.55; 9.00 
(p=0.456)  
(n=9) 
26.55; 9.29 
33.46; 7.45 
(p=0.101) 
(n=9) 
32.21; 11.24 
26.47; 10.97 
(p=0.289) 
(n=8) 
30.67; 7.67 
33.76; 15.87 
(p=0.625) 
B cells (% Mean; s.d.) 
Control  
Experimental 
 
7.88; 6.9; 
10.17; 2.66 
(p=0.369) 
 
6.33; 3.63  
8.87; 3.01 
(p=0.127) 
 
8.8; 5.18 
10.39; 2.55 
(p=0.421) 
 
5.31; 2.63  
14.78; 14.32 
(p=0.106) 
T cells (% Mean; s.d.) 
Control  
Experimental 
 
85.39; 9.84 
78.33; 6.99 
(p=0.099) 
 
87.09; 6.00 
77.97; 7.21 
(p=0.01) 
 
84.85; 8.92 
75.52; 9.24 
(p=0.05) 
 
88.32; 7.00 
75.18; 14.6 
(p=0.038) 
Table 11. Lymphocyte populations: Total lymphocytes, B cells and T cells. Comparison 
between groups at different time points (p<0.05, statistically significant).  
p=0.049 p=0.019 
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Graphic 2: Lymphocyte populations. Comparison between groups and across time. 
 
 
Effect of acupuncture on NK cells 
Statistically differences among groups on total NK cells and NK bright cells values  
were revealed after 2 sessions of AcuMoxa treatments (p=0.030, p= 0.024, respectively) 
and remained until T2 (p=0.039 and p= 0.038, respectively). At T3, it was verified a 
decrease in total NK cells. This may be due to the fact that two patients have mouth 
infections and received antibiotics treatment, and two other patients (one on control group 
and other on the experimental group) blood samples were coagulated impossibilitating the 
analyses of these patients in this time point. 
NK Dim subset become statistically different between the two groups after 6 
sessions of AcuMoxa treatment (p=0.034). 
Also, it is clear that experimental group reveals a increasing tendency, which is 
opposite to the observed in the control group: a decreasing tendency (Graphic 3). 
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Graphic 3: NK cells and subsets. *at T3, n=7. 
 
 
Effect of acupuncture on Anxiety and Depression Levels 
The comparison of the two groups at the begining of the study shows an worse 
emotional status of patients on the experimental (Graphic 4). After intervention differences 
among the groups were verified: the AcuMoxa group have a lower score of anxiety and 
depression when compared with the control group; the control group reveals worse scores 
at the end of the study than in the begining. Moreover, a negative correlation between 
depression and anxiety scores and NK cells was revealed (p=0.015 and p=0.003, 
respectively). 
 
Graphic 4: Comparison of Anxiety and Depression scores among groups, at begining and at 
the end of the study. 
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Effect of Acupuncture on patients QOL 
It was not identified differences among groups most probably due to the fact that 
was a short period of intervention and follow-up of patients (3 weeks of AcuMoxa 
treatments). However, the data collected shows a tendency of reduction of several 
symptoms such as gastrointestinal symptoms, urological symptoms, stoma-related 
symptoms, chemotherapy side effects, sexual function (male) and also about concerns on 
weight and future perspectives. 
 
 
 
 
Graphic 5: QOL assessment through questionnaire CR29 (I). 
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Graphic 6: QOL assessment through questionnaire CR29 (II). 
 
 
 
Adverse events during the study period 
No adverse events occurred during the study period. 
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2. Discussion 
 
CRC is one of the most common cancers and a major cause of death due to 
cancer worldwide. The functional state of the host immune system has a major prognostic 
and predictive impact on the fate of cancer patients treated with conventional or targeted 
chemotherapies.23 
 
Studies on CRC tumourigenesis and prognosis86, 87 showing that NK cell migration 
into tumour tissue is impaired in early stages of tumour development and that NK cells 
activity is reduced in metastatic CRC lead to conclude that NK cells have a pivot role on 
CRC tumourigenesis and being a first line of defense against metastasis. Moreover, 
Grivennikov et al revealed that the presence of NK cells in tumour immune 
microenvironment represents a positive prognostic marker, being the unique cells without 
a pro-tumourigenic role.5  
 
However, some West trials revealed that acupuncture modulates NK cell number 
and function in diverse clinical situations: in women with severe anxiety125 and in pain 
syndromes126 and also healthy volunteers108. 
 
There is a lack of data regarding the effect of acupuncture and moxibustion on 
CRC patients. In fact, only two eastern studies have addressed modulation of NK cells 
subset activity in CRC patients105,106 revealing that acupuncture and moxibustion 
increased T lymphocyte subsets as well as NK cells.  
 
To our knowledge, this is the first controlled clinical trial on acupuncture and 
moxibustion NK cells modulation in CRC conducted in the West. Although our results 
must be interpreted cautiously, due to small samples sizes, we found consistent trends of 
higher WBC, NK cells and its subsets in AcuMoxa group relative to control group of 
patients with colorectal cancer undergoing chemotherapy.  
Our results reveal that AcuMoxa protocol increases WBC counts and ANC 
resulting in approximately a 1,5 reduction in leukopenia and neutropenia rates compared 
to the control group, suggesting a myeloprotective effect of acupuncture and consequently 
a reduction of treatment delays, chemotherapy regimens modifications (cycle delay, dose 
reduction), as well as reduction of supportive care costs. These observations must be 
conﬁrmed in future larger studies. However, our results are consistent with the results of 
other clinical trials referred in a meta-analysis100 and with a clinical trial on patients with 
ovarian cancer undergoing chemotherapy101. 
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Regarding to NK cells counts, our results revealed an increase of total NK cells 
and NKBright cells after one week of AcuMoxa treatment pointing to an immediate 
immunoregulatory effect of AcuMoxa treatment and a later cytotoxic effect: increase of 
NKdim cells after two weeks of AcuMoxa treatments. Our results are congruent with the 
literature15,18 that stresses that NKBright cells are immature precursors of NKdim cells that 
produces several cytokines, such as IFNγ, triggering the generation of tumour-specific 
TH1 T cells and CTL. The activation of CTL induces the antitumor activity of NK cells. In 
fact, IFN has been associated with antigen presentation stimulation through upregulation 
of MHC class I and II molecules on many cell types, modulation of leukocyte interactions 
with the endothelium, cell proliferation control and sensitivity to apoptosis, stimulation of 
the bactericidal activity of phagocytes and with the block of angiogenesis. 
Moreover, Yu et al17 found that during the NK cells maturation process occurs a 
successive and signiﬁcant decrease in cytokine-mediated proliferation and IFN 
production, an increase in granzyme B and perforin 1 expression, and CD94-mediated 
redirected killing. 
 
 
As described previously, psychological and emotional stress has negative 
implications for increased symptom perception and poor quality of life, and is significantly 
associated with decreased lymphocyte percentage, and more specifically with decreased 
NK cells numbers and activity.24 In fact, some studies showed an association between 
stress reduction in cancer trajectory and improvement of immune responses in women 
with breast cancer. 24 
Our results are consistent with the literature showing that anxiety and depression 
levels decrease with increasing NK cells values and indicating a negative correlation 
between depression and anxiety levels and NK cells. 
Moreover, Arranz et al reported that acupuncture improve impaired immune 
functions on anxious women (chemotaxis, phagocytosis, lymphoproliferation and NK 
activity) and that acupuncture reversed the lowering of IL-2 levels and elevating of TNF-
alpha and cortisol seen in anxious women. 
 
In respect to quality of life, our study do not express any statistically significant 
results. This is probably due to the short period of treatment (only three weeks; 6 
AcuMoxa treatments). However, the results shows a tendency of decreasing of certain 
symptoms, such as gastrointestinal symptoms, urological symptoms and chemotherapy 
side effects as well as the improvement of sexual function in men. Also, shows a tendency 
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of improvement about the patients owns future perspectives, a loss of concern about 
weight and body image. 
 
 It is know that the higher frequency and severity of clinical symptoms are 
associated with significant levels of depression and anxiety in cancer patients. From our 
preliminary results we can conclude that the improvement of the immune system induces 
a decrease of anxiety and depression levels and consequently improves the QOL of CRC 
patients (Fig. 18). 
 
 
Figure 18: Effects of AcuMoxa protocol in immune system, according to Heidelberg 
Model of TCM. 
 
 
Regarding to the mechanism through which acupuncture acts on the immune 
system is generally accepted that an increase on the release of endogen opiod peptid is 
the key pathway. (Han et al., 1999) 
Takahashi et al,104 reviewed the ascribed immunomodulation of acupuncture and 
conclude that acupuncture treatment appears to be able to modulate immunosuppressed 
or immunoactivated conditions through various functions. In general, immunomodulatory 
effects of acupuncture might be expressed under three categories: local, neuronal and 
neurohumoral immunomodulation.  
As previously described (chapter 3, section 4), Johnston hypothesized that 
acupuncture may promote secretion of opioid peptides, induced by the action of nitric 
oxide (NO) into several central pathways. β-endorphin may then influence immune cells 
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by binding to opiod receptors on the surface of NK cells. Consequently, it would promote 
tumoricidal activity through the expression of cytotoxic molecules and production of IFNγ. 
This cytokine would further increase the expression of NK cell receptors and possibly 
cytokine secretion by other immune cells, thereby amplifying anticancer immune 
functions.  
On the other hand, two more mechanisms were addressed to acupuncture 
immunomodulation effects: the regulation of the NK-related gene expression in the 
spleen105 and the regulation of sympathetic nervous system (SNS). 
In fact, the activation of HPA axis and SNS, that occurs in cancer, results in high 
levels of catecolamines and glucocorticoids, which increases sympathetic outflow and 
decreases NK activity in the periphery: citotoxicity diminishes in 1 hour and NK counts 
diminishes in 20 min. Catecolamines affect predominantly NK cells and can suppress 
them indirectly, by their selective suppression of Th1 response and inhibition of IL12 and 
IFNγ, and directly due to the high amounts of β2-adrenoreceptors (corticotropine-release 
hormone-SNS axis).  
Thus, we can foresee that acupuncture acts on the SNS and the HPA axis, 
diminishing the levels of catecolamines and consequently reduce the suppressive effects 
of catecolamines on NK cells, allowing the maturation of NKbright to NKdim cells and the 
balancing Th1 and Th2 responses. 
 
In summary, our study protocol provide evidence that acupuncture and 
moxibustion may stimulate anticancer immunity via activation and subsequent 
differentiation of NK cells, through regulation of the SNS and the HPA axis. As 
consequence it is achieved the improvement of the immune system status, the reduction 
of chemotherapy side effects, as well as the improvement the quality of life of CRC 
patients.  
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Figure 19. Simplified scheme of acupuncture mechanisms of action on the NK cells 
tumoricidal activity. 
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CONCLUSIONS 
 
Current literature data supports a plausible effect of acupuncture 
immunomodulation via activation of NK cells. These cells act both on innate and adaptive 
immunity.  
Our clinical research protocol revealed that acupuncture/moxa treatment according 
to the Heidelberg Model of Traditional Chinese Medicine promote NK cells activity, initially 
stimulates the immunoregulatory activity and later the cytotoxic activity, resulting on the 
improvement of the immune system, of the psychoemotional status, and of the QOL of 
CRC patients, as well as in the reduction of chemotherapy side effects in CRC patients.  
 
In the future, this complementary treatment might have a positive impact in the 
prognosis and QOL of CRC patients and may constitute an adjuvant strategy on the 
conventional treatment of CRC as well as on the treatment of other cancers. 
In fact, NK cells are being feasible targets of immunotherapeutic approaches like 
antibody-based strategies. However, there is some limitations regarding the toxicity of 
these therapies using interleucine. Acupuncture treatment appears to be a possible and 
efficient strategy that overcomes such limitations. 
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INFORMAÇÃO AO PARTICIPANTE 
Caro Participante, 
Este estudo designa-se “O efeito da acupuntura na função imunológica de doentes com 
cancro colo-retal submetidos a quimioterapia”. O investigador principal é a dra. Irene 
Pais que poderá contactar sempre que necessário para telemóvel 917993644. 
Pretende-se com este estudo avaliar os efeitos da acupuntura no sistema imunitário em 
doentes com tumor colo-retal submetidos a quimioterapia. A participação neste estudo é de 
carácter voluntário e dela não resultará qualquer interferência com o seu tratamento 
médico habitual. Terá o tempo que entender necessário para decidir livremente sobre a sua 
participação este estudo. A qualquer momento poderá retirar-se do curso, sem qualquer 
comprometimento da sua relação com os médicos ou dos seus direitos assistenciais. 
Este estudo será conduzido no Serviço de Oncologia e em colaboração com o Serviço de 
Patologia Clínica do Centro Hospitalar de São João. Serão convidados a participar neste 
estudo doentes com cancro colo-retal submetidos a tratamento de quimioterapia. Para tal é 
necessário que assine o documento de consentimento informado. 
Esta avaliação implicará a comparação de um tratamento “verdadeiro” de acupunctura com 
um tratamento “falso” de acupuntura. Através de um sorteio, cada participante poderá ser 
incluído no grupo “verdadeiro” (acupuntura/moxabustão verdadeira) ou no grupo “falso” 
(grupo sem tramento de acupunctura). Serão usadas agulhas de acupuntura descartáveis de 
36G, 0,20x25mm, de aço inoxidável e revestidas de silicone (Tewa®). A profundidade da 
agulha será de aproximadamente 10 mm. Na terapia de moxabustão serão usados cones 
ocos auto-adesivos de moxa (Artemisia vulgaris) sobre os pontos de acupuntura. O 
tratamento terá a duração de aproximadamente 30 minutos. Sendo a acupuntura uma 
técnica de baixo custo e com raros efeitos laterais quando executada por profissionais de 
formação acreditada, o impacto desta técnica terapêutica é sempre mínimo. 
No caso de se obterem resultados considerados benéficos com o tratamento verdadeiro, os 
participantes do grupo “falso” serão convidados para realizarem um tratamento verdadeiro. 
Todos os dados serão tratados com privacidade e confidencialidade. 
Será necessário estar disponível para 2 a 3 tratamentos de acupuntura durante a semana e 
para 3 colheitas de sangue venoso periférico. 
Este estudo foi aprovado pela Comissão de Ética para a Saúde do Centro Hospitalar de São 
João.  
A investigadora principal 
Dra Irene Pais 
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Appendix 3. Socio-demographic, QOL and HADS questionnaires 
 
I - QUESTIONÁRIO SÓCIO-DEMOGRÁFICO 
 
Por favor, responda às seguintes questões gerais. 
 
1. Idade: ______anos 2. Data de Nascimento: ______/______/_________ 
3. Género:  0. ____ Feminino 1. ____ Masculino 
4. Estado Civil: 0___Casado(a) ou união de facto  1.___ Solteiro(a)  
  2.___Divorciado(a) ou separado(a)  3.___Viúvo(a) 
5. Habilitações Literárias: 0.___ 1º Ciclo; 1.___ 2º Ciclo  
     2.___ Secundário 3.___Ensino Superior 
6. Profissão: ___________________________________________________________ 
7. Situação Profissional: 0.__Estudante 1.___Empregado(a) 2.___ 
Desempregado     3.___ Baixa médica  5.___ Reformado(a) 
8. Concelho de residência: _________________________________________________ 
9. Religião: 0.____Católico 1.___Agnóstico(a)      
 2.___Evangélico(a) 3.___Testemunha de Jeová 
10. Tempo que passou desde o diagnóstico: ___________________ 
11. Com quem mora:  0.___Sozinho  1.___Companheiro(a) e Filho(s) 
     2.___Pais   3.___Companheiro(a) e Filho(s) 
     4.___Outros 
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II A - EORTC QLQ - CR29 
 
Por favor, indique o grau de ocorrência dos seguintes sintomas durante a semana passada. 
Por favor, responda assinalando com um círculo no número que melhor descreve a sua 
saúde. 
NA ÚLTIMA SEMANA: NÃO POUCO MODERADO MUITO 
31. Urinou frequentemente durante o dia? 1 2 3 4 
32. Urinou frequentemente durante a noite? 1 2 3 4 
33. Teve algum episódio de incontinência 
urinária? 
1 2 3 4 
34. Sentiu dor durante a micção? 1 2 3 4 
35. Sentiu dor abdominal? 1 2 3 4 
36. Sentiu dor no ânus ou reto? 1 2 3 4 
37. Teve sensação de inchaço abdominal? 1 2 3 4 
38. Verificou a presença de sangue nas fezes? 1 2 3 4 
39. Verificou a presença de muco nas fezes? 1 2 3 4 
40. Sentiu a boca seca? 1 2 3 4 
41. Teve queda de cabelo? 1 2 3 4 
42. Teve perda de paladar? 1 2 3 4 
43. Esteve preocupado(a) com a sua saúde no 
futuro? 
1 2 3 4 
44. Esteve preocupado(a) com o seu peso? 1 2 3 4 
45. Sentiu-se menos atrativo(a) fisicamente? 1 2 3 4 
46. Sentiu-se menos feminina/masculino? 1 2 3 4 
47. Sentiu-se insatisfeito(a) com o seu corpo? 1 2 3 4 
48. Possui um saco de colostomia? Não    Sim 
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RESPONDA ÀS SEGUINTES QUESTÕES  
APENAS SE USAR UM SACO DE COLOSTOMIA 
 
NA ÚLTIMA SEMANA 
 
NÃO POUCO MODERADO MUITO 
49. Teve episódios de libertação intencional de 
flatulência do saco? 
1 2 3 4 
50. Teve perda de fezes através do saco? 1 2 3 4 
51. Possui a pele dorida em volta do estoma? 1 2 3 4 
52. Efetua frequentemente mudanças de saco 
durante o dia? 
1 2 3 4 
53. Efetua frequentemente mudanças de saco 
durante a noite? 
1 2 3 4 
54. Sente-se envergonhado devido ao uso de 
saco? 
1 2 3 4 
55. Tem problemas em transportar o saco? Não   Sim 
 
 
RESPONDA ÀS SEGUINTES QUESTÕES APENAS SE NÃO USAR UM SACO DE 
COLOSTOMIA 
NA ÚLTIMA SEMANA 
 
NÃO POUCO MODERADO MUITO 
49.Teve episódios de libertação intencional de 
flatulência? 
1 2 3 4 
50. Teve perda de fezes? 1 2 3 4 
51. Possui a pele dorida em volta do ânus? 1 2 3 4 
52. Ocorrem movimentos intestinais frequentes 
durante o dia? 
1 2 3 4 
53. Ocorrem movimentos intestinais frequentes 
durante a noite? 
1 2 3 4 
54. Sente-se envergonhado devido aos 
movimentos intestinais? 
1 2 3 4 
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NAS ÚLTIMAS 4 SEMANAS 
 
NÃO POUCO MODERADO MUITO 
Para os Homens apenas 
56. Teve interesse sexual? 
 
1 
 
2 
 
3 
 
4 
57. Teve dificuldade em ter ou manter uma 
ereção?              
1 2 3 4 
 
Para Mulheres apenas 
    
58. Teve interesse sexual? 1 2 3 4 
59. Sentiu dor ou desconforto durante a relação 
sexual? 
1 2 3 4 
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II B – QUESTIONÁRIO EORTC  QLQ – LMC21 
 
Por favor, indique o grau de ocorrência dos seguintes sintomas durante a semana passada. Por 
favor, responda assinalando com um círculo no número que melhor descreve a sua saúde. 
 
 
NA ÚLTIMA SEMANA: NÃO POUCO MODERADO MUITO 
31. Teve falta de apetite? 1 2 3 4 
32. Teve sensação de saciedade logo após início 
da refeição? 
 
1 
 
2 
 
3 
 
4 
33. Sentiu perda ou alteração de paladar? 1 2 3 4 
34. Sentiu dor durante a micção? 1 2 3 4 
35. Sentiu a boca seca? 1 2 3 4 
36. Tem feridas na boca ou na língua? 1 2 3 4 
37. Tem estado menos ativo do que desejaria? 1 2 3 4 
38. Sentiu formigueiro nas mãos ou pés? 1 2 3 4 
39. Sentiu dor no estômago? 1 2 3 4 
40. Sentiu desconforto no estômago? 1 2 3 4 
41. Teve a pele ou os olhos amarelos? 1 2 3 4 
42. Sentiu dor nas costas? 1 2 3 4 
43. Sentiu-se mais lento(a)? 1 2 3 4 
44. Sentiu falta de energia? 1 2 3 4 
45. Sentiu dificuldades em conviver com amigos? 1 2 3 4 
46. Teve dificuldades em falar sobre os seus 
sentimentos com família ou amigos? 
 
1 
 
2 
 
3 
 
4 
47. Sentiu-se sobre stress? 1 2 3 4 
48. Sentiu-se menos capaz em se divertir? 1 2 3 4 
49. Preocupou-se com o seu futuro estado de 
saúde? 
1 2 3 4 
50. Preocupou-se com a sua família no futuro? 1 2 3 4 
Nas últimas 4 semanas:     
51. A doença ou tratamento afetou (para pior) a 
sua vida sexual? 
 
1 
 
2 
 
3 
 
4 
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III - ESCALA DE ANSIEDADE E DEPRESSÃO HOSPITALAR 
 (versão Portuguesa-Pais Ribeiro) 
 
Este questionário foi construído para ajudar a saber como se sente. Pedimos-lhe que leia 
cada uma das perguntas e faça uma cruz (X) no espaço anterior à resposta que melhor 
descreve a forma como se tem sentido na última semana.  
 
1. Sinto-me tenso/a ou nervoso/a: 
( ) Quase sempre   ( )Muitas vezes ( ) Por vezes  ( ) Nunca 
2. Ainda sinto prazer nas coisas de que costumava gostar: 
( ) Tanto como antes ( ) Não tanto agora ( ) Só um pouco ( ) Quase nada 
3. Tenho uma sensação de medo, como se algo terrível estivesse para acontecer: 
( ) Sim e muito forte  ( ) Sim, mas não muito forte  
( ) Um pouco, mas não me aﬂige   ( ) De modo algum 
4. Sou capaz de rir e ver o lado divertido das coisas: 
( ) Tanto como antes ( ) Não tanto como antes ( ) Muito menos agora 
( ) Nunca 
5. Tenho a cabeça cheia de preocupações: 
( ) A maior parte do tempo ( ) Muitas vezes ( ) Por vezes   
( ) Quase nunca 
6. Sinto-me animado/a: 
( ) Nunca ( ) Poucas vezes ( ) De vez em quando  ( ) Quase sempre 
7. Sou capaz de estar descontraidamente sentado/a e sentir-me relaxado/a: 
( ) Quase sempre  ( )Muitas vezes ( ) Por vezes  ( ) Nunca 
8. Sinto-me mais lento/a, como se ﬁzesse as coisas mais devagar: 
( ) Quase sempre  ( ) Muitas vezes ( ) Por vezes  ( ) Nunca 
9. Fico de tal forma apreensivo/a (com medo), que até sinto um aperto no estômago: 
( ) Nunca  ( ) Por vezes  ( )Muitas vezes ( ) Quase sempre 
10. Perdi o interesse em cuidar do meu aspeto físico: 
( ) Completamente ( ) Não dou a atenção que devia 
( ) Talvez cuide menos que antes 
( ) Tenho o mesmo interesse de sempre 
11. Sinto-me de tal forma inquieto/a que não consigo estar parado/a: 
( )Muito ( ) Bastante  ( ) Não muito  ( ) Nada 
12. Penso com prazer nas coisas que podem acontecer no futuro: 
( ) Tanto como antes ( ) Não tanto como antes ( ) Bastante menos agora 
( ) Quase nunca 
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13. De repente, tenho sensações de pânico: 
( ) Muitas vezes ( ) Bastantes vezes  ( ) Por vezes  ( ) Nunca 
14. Sou capaz de apreciar um bom livro ou um programa de rádio ou televisão: 
( ) Muitas vezes ( ) De vez em quando  ( ) Poucas vezes 
( ) Quase nunca 
 
